<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005520.pub3" GROUP_ID="ORAL" ID="168605010608324442" MERGED_FROM="" MODIFIED="2016-11-01 11:06:18 +0000" MODIFIED_BY="Luisa Fernandez Mauleffinch" REVIEW_NO="0148" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2016-11-01 11:04:33 +0000" MODIFIED_BY="[Empty name]">
<TITLE>Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children</TITLE>
<CONTACT>
<PERSON ID="7B97B89E82E26AA2014A5594446D09E9" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Fernando</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Carvalho</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>odontofernandocarvalho@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Neuro-Sono Sleep Center, Department of Neurology</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Americo Salvador Novelli 508</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>08210-090</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 36819642</PHONE_1>
<PHONE_2/>
<FAX_1>+55 11 36819642</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2016-11-01 11:03:45 +0000" MODIFIED_BY="Luisa Fernandez Mauleffinch">
<PERSON ID="7B97B89E82E26AA2014A5594446D09E9" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Fernando</FIRST_NAME>
<MIDDLE_INITIALS>R</MIDDLE_INITIALS>
<LAST_NAME>Carvalho</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>odontofernandocarvalho@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Neuro-Sono Sleep Center, Department of Neurology</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Americo Salvador Novelli 508</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>08210-090</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 36819642</PHONE_1>
<PHONE_2/>
<FAX_1>+55 11 36819642</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7B97B78482E26AA2014A55941DC3136E" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Débora</FIRST_NAME>
<MIDDLE_INITIALS>A</MIDDLE_INITIALS>
<LAST_NAME>Lentini-Oliveira</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>deblentini@terra.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Neuro-Sono Sleep Center, Department of Neurology</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Cláudio Rossi 394</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>CEP 01547-000</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 15 32320832</PHONE_1>
<PHONE_2/>
<FAX_1>+55 15 32320832</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7B97BA2482E26AA2014A55948F8A57B9" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Lucila</FIRST_NAME>
<MIDDLE_INITIALS>BF</MIDDLE_INITIALS>
<LAST_NAME>Prado</LAST_NAME>
<SUFFIX/>
<POSITION>Clinical Coordinator of Neuro-Sono Sleep Medicine</POSITION>
<EMAIL_1>lucilaunifesp@gmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Neurology</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Claudio Rossi,394</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>01547-000</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 5081 6629</PHONE_1>
<PHONE_2>+55 11 55728205</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="38D0FA0C82E26AA201BA4B547DC85853" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Gilmar</FIRST_NAME>
<MIDDLE_INITIALS>F</MIDDLE_INITIALS>
<LAST_NAME>Prado</LAST_NAME>
<SUFFIX/>
<POSITION>Professor</POSITION>
<EMAIL_1>gilmarunifesp@yahoo.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Neurology</DEPARTMENT>
<ORGANISATION>Escola Paulista de Medicina, Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP/>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 5081 6629</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="71568C7F82E26AA200CE0284C573E0D4" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Luciane</FIRST_NAME>
<MIDDLE_INITIALS>BC</MIDDLE_INITIALS>
<LAST_NAME>Carvalho</LAST_NAME>
<SUFFIX>PhD</SUFFIX>
<POSITION/>
<EMAIL_1>lucianebizari@yahoo.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Neurology</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Claudio Rossi, 394</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>CEP 01547-000</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 50816629</PHONE_1>
<PHONE_2>+55 11 50816629</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2016-10-03 12:16:36 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="7" MONTH="4" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="7" MONTH="4" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="15" MONTH="10" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="10" YEAR="2016"/>
</DATES>
<WHATS_NEW MODIFIED="2016-11-01 11:04:33 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="STABLE" MODIFIED="2016-11-01 11:04:33 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="11" YEAR="2016"/>
<DESCRIPTION>
<P>This review will not be updated until a substantial body of evidence on the topic becomes available. If trials are conducted and found eligible for inclusion in the future, the review would then be updated accordingly</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2016-11-01 11:04:08 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2016-11-01 11:04:05 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="9" YEAR="2016"/>
<DESCRIPTION>
<P>Two of the original authors not involved in the update. A new author was added.<BR/>Background and methods sections updated. 'Risk of bias' assessment completed. 'Summary of findings' table added</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2016-11-01 11:04:08 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="7" MONTH="4" YEAR="2016"/>
<DESCRIPTION>
<P>Searches updated to April 2016. No new studies found for inclusion</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2016-07-27 00:04:29 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<DATE DAY="1" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2016-10-03 23:07:30 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2016-10-03 23:07:30 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<SOURCE MODIFIED="2016-07-25 14:44:01 +0100" MODIFIED_BY="[Empty name]">
<NAME>Brazilian Cochrane Center</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2016-07-25 14:45:29 +0100" MODIFIED_BY="[Empty name]">
<NAME>National Institute for Health Research (NIHR)</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION>
<P>This project was supported by the NIHR, via Cochrane Infrastructure funding to Cochrane Oral Health. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, the NIHR, the NHS or the Department of Health.</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2016-10-03 23:07:30 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<NAME>Cochrane Oral Health Global Alliance</NAME>
<COUNTRY CODE="NONE">Other</COUNTRY>
<DESCRIPTION>
<P>The production of Cochrane Oral Health reviews has been supported financially by our Global Alliance since 2011 (<A HREF="http://ohg.cochrane.org/partnerships-alliances">ohg.cochrane.org/partnerships-alliances</A>). Contributors over the last year have been: British Association for the Study of Community Dentistry, UK; British Society of Paediatric Dentistry, UK; Centre for Dental Education and Research at All India Institute of Medical Sciences, India; National Center for Dental Hygiene Research &amp; Practice, USA; New York University College of Dentistry, USA; NHS Education for Scotland, UK.</P>
</DESCRIPTION>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2016-11-01 11:05:11 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2016-10-03 23:11:04 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<TITLE MODIFIED="2016-06-25 13:54:32 +0100" MODIFIED_BY="[Empty name]">Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children</TITLE>
<SUMMARY_BODY MODIFIED="2016-10-03 23:11:04 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>
<B>Review question</B>
</P>
<P>Are oral appliances and functional orthopaedic appliances effective and safe for treating children with obstructive sleep apnoea syndrome?</P>
<P>
<B>Background</B>
</P>
<P>Obstructive sleep apnoea in children is a breathing disorder characterized by episodes of partial or complete upper airway obstruction that occur during sleep. There are various risk factors and is associated with daytime and night-time symptoms including among others sleepiness, irritability, tiredness, morning headaches, nasal stuffiness, habitual snoring, nightmares, etc. The common treatment for obstructive sleep apnoea in childhood is adeno-tonsillectomy, the removal of the adenoids and tonsils. This approach is limited by recurrence that can be associated with craniofacial problems. Oral/functional orthopaedic appliances have been used for patients who have obstructive sleep apnoea and craniofacial anomalies because they hold the lower jaw (mandible) forwards which potentially enlarges the upper airway and increases the upper airspace, improving the respiratory function.</P>
<P>
<B>Study characteristics</B>
</P>
<P>The evidence on which this review is based was current as of 7 April 2016. It included only one study in which 32 children were randomised to receive an oral appliance or no treatment. Twenty-three participants finished the study.</P>
<P>
<B>Key results</B>
</P>
<P>Treatment of obstructive sleep apnoea syndrome in children appears to be possible with oral appliances or functional orthopaedic appliances. However, this is only based on data from one small study.</P>
<P>
<B>Quality of the evidence</B>
</P>
<P>This was a study with a small number of participants and the quality of the evidence for the different outcomes was rated as very low. At present there is insufficient evidence to conclude that oral or functional orthopaedic appliances are effective in the treatment of obstructive sleep apnoea in children.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2016-10-03 23:10:53 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<ABS_BACKGROUND MODIFIED="2016-10-03 12:07:18 +0100" MODIFIED_BY="[Empty name]">
<P>Apnoea is a breathing disorder marked by the absence of airflow at the nose or mouth. In children, risk factors include adenotonsillar hypertrophy, obesity, neuromuscular disorders and craniofacial anomalies. The most common treatment for obstructive sleep apnoea syndrome (OSAS) in childhood is adeno-tonsillectomy. This approach is limited by its surgical risks, mostly in children with comorbidities and, in some patients, by recurrence that can be associated with craniofacial problems. Oral appliances and functional orthopaedic appliances have been used for patients who have OSAS and craniofacial anomalies because they hold the lower jaw (mandible) forwards which potentially enlarges the upper airway and increases the upper airspace, improving the respiratory function.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2016-07-27 11:38:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>To assess the effects of oral appliances or functional orthopaedic appliances for obstructive sleep apnoea in children.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2016-07-27 11:42:33 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>We searched the following electronic databases: Cochrane Oral Health's Trials Register (to 7 April 2016); Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 7 April 2016); MEDLINE Ovid (1946 to 7 April 2016); Embase Ovid (1980 to 7 April 2016); LILACS BIREME (from 1982 to 7 April 2016); BBO BIREME (from 1986 to 7 April 2016) and SciELO Web of Science (from 1997 to 7 April 2016). We searched ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform for ongoing trials on 7 April 2016. We placed no restrictions on the language or date of publication when searching the electronic databases.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2016-10-03 12:07:53 +0100" MODIFIED_BY="[Empty name]">
<P>All randomised or quasi-randomised controlled trials comparing all types of oral and functional orthopaedic appliances with placebo or no treatment, in children 15 years old or younger. Primary outcome: reduction of apnoea to less than one episode per hour. Secondary outcomes: dental and skeletal relationship, sleep parameters improvement, cognitive and phonoaudiological function, behavioural problems, quality of life, side effects (tolerability) and economic evaluation.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2016-07-27 11:46:12 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Two review authors screened studies and extracted data independently. Authors were contacted for additional information. We calculated risk ratios with 95% confidence intervals for all important dichotomous outcomes. We assessed the quality of the evidence of included studies using GRADEpro software.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2016-10-03 23:10:53 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>The initial search identified 686 trials. Only one trial, reporting the results from a total of 23 children and comparing an oral appliance to no treatment, was suitable for inclusion in the review. The trial assessed apnoea-hypopnoea, daytime symptoms (sleepiness, irritability, tiredness, school problems, morning headache, thirstiness in the morning, oral breathing and nasal stuffiness) and night-time symptoms (habitual snoring, restless sleep and nightmares measured by questionnaire). Results were inconsistent across outcomes measures and time points. The evidence was considered very low quality.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2016-10-03 12:15:41 +0100" MODIFIED_BY="[Empty name]">
<P>There is insufficient evidence to support or refute the effectiveness of oral appliances and functional orthopaedic appliances for the treatment of obstructive sleep apnoea in children. Oral appliances or functional orthopaedic appliances may be considered in specified cases as an auxiliary in the treatment of children who have craniofacial anomalies which are risk factors for apnoea.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2016-10-03 22:31:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<BACKGROUND MODIFIED="2016-10-03 15:53:01 +0100" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2016-10-03 12:58:17 +0100" MODIFIED_BY="[Empty name]">
<P>Apnoea is a breathing disorder marked by the absence of airflow through the nose or mouth. It is divided into central, obstructive and mixed apnoea. In central apnoea, airflow is absent due to the lack of respiratory efforts. In obstructive apnoea, airflow is absent, in spite of continuing respiratory efforts, due to the obstruction of the upper airway. In mixed apnoea, central and obstructive apnoea occurs sequentially with no normal breathing between the two events (<LINK REF="REF-Carroll-1995a" TYPE="REFERENCE">Carroll 1995a</LINK>).</P>
<P>Sleep disordered breathing is common in childhood (<LINK REF="REF-Nixon-2005" TYPE="REFERENCE">Nixon 2005</LINK>; <LINK REF="REF-Schechter-2002" TYPE="REFERENCE">Schechter 2002</LINK>). It occurs in children of all ages, from neonates to adolescents (<LINK REF="REF-Marcus-2001" TYPE="REFERENCE">Marcus 2001</LINK>). It is estimated that 0.8% to 24% of children are habitual snorers and that 1% to 5% have obstructive sleep apnoea syndrome (OSAS) (<LINK REF="REF-Marcus-2012" TYPE="REFERENCE">Marcus 2012</LINK>). OSAS in children is characterized by episodes of partial or complete upper airway obstruction that occur during sleep, usually associated with a reduction in oxyhaemoglobin saturation or hypercarbia or both (<LINK REF="REF-Carroll-1995a" TYPE="REFERENCE">Carroll 1995a</LINK>).</P>
<P>The aetiology is multifactorial. OSAS arises when the balance between the factors maintaining airway patency and those promoting airway collapse is perturbed. This balance is determined by the interactions of central ventilatory responses to hypoxia, hypercapnia and airway occlusion, upper-airway neuromuscular tone, the effects of sleep state and arousal, and the anatomic size and resistance of the upper airway (<LINK REF="REF-Ward-1996" TYPE="REFERENCE">Ward 1996</LINK>).</P>
<P>In children, risk factors include obesity, adenotonsillar hypertrophy, neuromuscular disorders and craniofacial anomalies (<LINK REF="REF-AAP-Guideline-2002" TYPE="REFERENCE">AAP Guideline 2002</LINK>; <LINK REF="REF-Kohler-2008" TYPE="REFERENCE">Kohler 2008</LINK>; <LINK REF="REF-Shintani-1998" TYPE="REFERENCE">Shintani 1998</LINK>). These factors can reduce the volume of the oronasopharyngeal cavity and can result in the tongue falling into the oropharynx (<LINK REF="REF-Viva-1992" TYPE="REFERENCE">Viva 1992</LINK>). There are many malocclusions associated with obstructive sleep apnoea, e.g. retrognathism/micrognathias, unilateral or bilateral cross bite, and open bite (<LINK REF="REF-Carvalho-2014" TYPE="REFERENCE">Carvalho 2014</LINK>; <LINK REF="REF-Defabjanis-2003" TYPE="REFERENCE">Defabjanis 2003</LINK>).</P>
<P>OSAS in children is associated with a series of daytime and night-time signs and symptoms. The daytime symptoms include excessive daytime sleepiness and abnormal daytime behaviour ranging from aggressiveness and hyperactivity to pathological shyness and social withdrawal, morning headaches and frequent upper airway infections. Nocturnal symptoms include difficult breathing whilst asleep, heavy snoring, apnoeic episodes, restless sleep, heavy sweating, nightmares, night terrors and enuresis (<LINK REF="REF-Guilleminault-1990" TYPE="REFERENCE">Guilleminault 1990</LINK>). Untreated obstructive sleep apnoea syndrome can result in serious morbidity. Early reports documented such complications as failure to thrive (<LINK REF="REF-Bell-2001" TYPE="REFERENCE">Bell 2001</LINK>), cor pulmonale and neurological dysfunction (<LINK REF="REF-Brouillette-1982" TYPE="REFERENCE">Brouillette 1982</LINK>), and other reports have suggested that children with OSAS have neurocognitive deficits (<LINK REF="REF-Goldstein-2000" TYPE="REFERENCE">Goldstein 2000</LINK>), such as poor learning, behavioural problems (<LINK REF="REF-Bell-2001" TYPE="REFERENCE">Bell 2001</LINK>), attention deficit hyperactivity disorder (<LINK REF="REF-AAP-Guideline-2002" TYPE="REFERENCE">AAP Guideline 2002</LINK>; <LINK REF="REF-Chervin-1997" TYPE="REFERENCE">Chervin 1997</LINK>) and systemic inflammation (<LINK REF="REF-Kheirandish_x002d_Gozal-2006" TYPE="REFERENCE">Kheirandish-Gozal 2006</LINK>). However, the symptoms can be very varied and difficult to detect (<LINK REF="REF-Carroll-2003" TYPE="REFERENCE">Carroll 2003</LINK>).</P>
<P>Diagnosis of OSAS may be based on information obtained by clinical history, physical examination and laboratory studies (<LINK REF="REF-Carroll-1995b" TYPE="REFERENCE">Carroll 1995b</LINK>). The 'gold standard' for the diagnosis of OSAS is polysomnography (<LINK REF="REF-AAP-Guideline-2002" TYPE="REFERENCE">AAP Guideline 2002</LINK>; <LINK REF="REF-Schechter-2002" TYPE="REFERENCE">Schechter 2002</LINK>), which is made up of channels for electrocardiography (ECG), electroencephalography (EEG), electroculography (EOG), electromyography (EMG), nasal and oral airflow, chest and abdominal movements, pulse oximetry arterial oxygen saturation (SpO<SUB>2</SUB>) and end tidal carbon dioxide tension (PETCO<SUB>2</SUB>) (<LINK REF="REF-Uliel-2004" TYPE="REFERENCE">Uliel 2004</LINK>). Polysomnography provides information on a number of sleep-related parameters: number and duration of complete or partial obstructions per hour of sleep, lowest oxygen saturation during each event, time spent below a given level of oxygen saturation during the night, presence and type of cardiac arrhythmias, and presence and severity of respiratory disturbances and their impact on the cardiovascular system. It also provides information on the severity of sleep disruption (<LINK REF="REF-Guilleminault-1990" TYPE="REFERENCE">Guilleminault 1990</LINK>).</P>
<P>Treatment for OSAS must be based on the assessment, duration and severity of symptoms and the anatomic structural and physiological abnormalities and their associated severity (<LINK REF="REF-Carroll-1995b" TYPE="REFERENCE">Carroll 1995b</LINK>). There are several treatments for OSAS in childhood, like alteration of the sleeping position, continuous positive airways pressure (CPAP), weight loss (<LINK REF="REF-AAP-Guideline-2002" TYPE="REFERENCE">AAP Guideline 2002</LINK>), tracheostomy, maxillomandibular advancement (<LINK REF="REF-Bell-2001" TYPE="REFERENCE">Bell 2001</LINK>), uvulopalatopharyngoplasty, oral appliances and adeno-tonsillectomy (<LINK REF="REF-AAP-Guideline-2002" TYPE="REFERENCE">AAP Guideline 2002</LINK>; <LINK REF="REF-Schechter-2002" TYPE="REFERENCE">Schechter 2002</LINK>).</P>
<P>The most common treatment for obstructive sleep apnoea syndrome in childhood is adeno-tonsillectomy, but this approach is limited by its surgical risks (<LINK REF="REF-Chan-2004" TYPE="REFERENCE">Chan 2004</LINK>). In some patients there is recurrence of the OSA especially in those with underlying skeletal deformities e.g. retrognathic mandible or constricted maxilla or both (<LINK REF="REF-Guilleminault-1989" TYPE="REFERENCE">Guilleminault 1989</LINK>). Children who do not improve after adeno-tonsillectomy tend to have a narrower epipharyngeal air space, a more poorly developed maxilla and mandibular retrusion (<LINK REF="REF-Shintani-1998" TYPE="REFERENCE">Shintani 1998</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2016-10-03 15:53:01 +0100" MODIFIED_BY="[Empty name]">
<P>Functional orthopaedic appliances are usually removable intraoral devices which alter the muscle forces against the teeth and facial skeleton i.e. maxilla and mandible. These are dynamic appliances which depend on altered neuromuscular action to affect bony growth and occlusal development. </P>
</INTERVENTION>
<THEORY MODIFIED="2016-06-12 23:14:49 +0100" MODIFIED_BY="[Empty name]">
<P>Functional orthopaedic appliances have been used for patients who have OSAS and craniofacial anomalies because functional orthopaedic appliances posture the mandible forwards and potentially enlarge the upper airway and increase the upper airspace, improving the respiratory function (<LINK REF="REF-Defabjanis-2003" TYPE="REFERENCE">Defabjanis 2003</LINK>; <LINK REF="REF-Viva-1992" TYPE="REFERENCE">Viva 1992</LINK>). </P>
</THEORY>
<IMPORTANCE MODIFIED="2016-10-03 13:28:30 +0100" MODIFIED_BY="[Empty name]">
<P>OSAS in children has been shown to be a prevalent condition and also a disease that can cause a number of other medical and/or social problems if left untreated. Many adults' OSAS started in childhood or adolescence so the importance of recognizing OSAS in childhood and the need for appropriate treatment should be emphasized to avoid potential long-term complications in adulthood. If the problem is recognized and treated early, there is a potential to reduce the economic costs to the health system (<LINK REF="REF-Tarasiuk-2007" TYPE="REFERENCE">Tarasiuk 2007</LINK>) and improve the quality of life for sufferers (<LINK REF="REF-Nixon-2005" TYPE="REFERENCE">Nixon 2005</LINK>). This review updates the previous version published in 2007 (<LINK REF="REF-Carvalho-2007" TYPE="REFERENCE">Carvalho 2007</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2016-07-26 10:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of oral appliances or functional orthopaedic appliances for obstructive sleep apnoea in children.</P>
</OBJECTIVES>
<METHODS MODIFIED="2016-10-03 22:12:49 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<SELECTION_CRITERIA MODIFIED="2016-10-03 15:54:49 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2016-07-26 10:39:45 +0100" MODIFIED_BY="[Empty name]">
<P>We aimed to identify all randomised controlled trials (RCTs). Trials using quasi-random methods of allocation (such as alternation, date of birth, record number) were included and would have been subjected to a sensitivity analysis.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2016-10-03 15:50:05 +0100" MODIFIED_BY="[Empty name]">
<P>Children and adolescents. We included trials in which over 80% of included participants were 15 years old or younger, receiving oral appliances or functional orthopaedic appliances to treat obstructive sleep apnoea. Criteria for abnormal values for obstructive apnoea in children considered as one or more apnoea, of any length, per hour of sleep, measured by standard polysomnography (<LINK REF="REF-Marcus-1992" TYPE="REFERENCE">Marcus 1992</LINK>). Trials including patients with a cleft lip or palate or both were excluded. There was no gender restriction.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2016-07-26 10:42:23 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention group: All types of oral and functional appliances used to treat obstructive sleep apnoea were compared to placebo or no treatment. Several types of appliances are used for this situation including: Bimler appliance, Frankel appliance, Harvold appliance, Andresen appliance, Bionator, bite block, Herbst appliance, Herren activator and Woodside activator.</P>
<P>Control group: Placebo or no treatment.</P>
<P>We excluded trials including other interventions like continuous positive airways pressure (CPAP), weight loss (dietary intervention), lifestyle modification, tracheostomy, maxillomandibular surgery, uvulopalatopharyngoplasty and adeno-tonsillectomy.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2016-10-03 15:54:49 +0100" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2016-10-03 15:54:13 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Reduction to less than one episode of apnoea per hour measured by standard polysomnography.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2016-10-03 15:54:49 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Reduction of apnoea episodes measured by standard polysomnography.</LI>
<LI>Reduction of upper airway resistance syndrome (UARS) measured by standard polysomnography and body-weight development curve compared by graphic of body mass index for age percentiles.</LI>
<LI>Reduction of snoring measured by standard polysomnography.</LI>
<LI>Signs and symptoms of respiratory disease: mouth breathing, nasal airway resistance measured by clinical assessment or rhinomanometry or fibroscopy.</LI>
<LI>Signs and symptoms of atypical swallowing, and speech production disturbance measured by validated tests for speech production or videofluoroscopy or clinical assessment.</LI>
<LI>Daytime and nocturnal symptoms e.g. daytime sleepiness, behavioural problems, nightmares.</LI>
<LI>Change of mandibular length measured by cephalometric data.</LI>
<LI>Improvement on sagittal relationship between the maxilla-mandible measured by cephalometric data.</LI>
<LI>Changes of the width between cuspids and first molars measured by plaster models.</LI>
<LI>Change of the arch perimeter measured by plaster models.</LI>
<LI>Improvement of the overbite and overjet measured by plaster models.</LI>
<LI>Alteration of growth pattern measured in cephalometric data or facial analysis.</LI>
<LI>Quality of life measured by validated scale.</LI>
<LI>Side effects - tolerability - measured by patient's self report.</LI>
<LI>Economic evaluation - costs.</LI>
<LI>Educational outcomes: cognitive function measured by validated scale.</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2016-07-26 11:59:54 +0100" MODIFIED_BY="[Empty name]">
<P>To identify studies for this review, we developed detailed search strategies for each database searched. These were based on the search strategy developed for MEDLINE (Ovid) but revised appropriately for each database. The search strategy used a combination of controlled vocabulary and free text terms and was linked with the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials (RCTs) in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the <I>Cochrane Handbook for</I> <I>Systematic Reviews of Interventions</I> Version 5.1.0 (updated March 2011) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>)<I>.</I> Details of the MEDLINE search are provided in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The Embase subject search was linked to an adapted version of the Cochrane Embase Project filter for identifying RCTs in Embase via Ovid (<I>see</I> <A HREF="http://www.cochranelibrary.com/help/central-creation-details.html">http://www.cochranelibrary.com/help/central-creation-details.html</A> for information). Searches of LILACs and BBO were linked to the Brazilian Cochrane Center filter for identifying RCTs.</P>
<ELECTRONIC_SEARCHES MODIFIED="2016-07-26 11:27:08 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the following electronic databases:</P>
<UL>
<LI>Cochrane Oral Health's Trials Register (searched 7 April 2016) (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>);</LI>
<LI>Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 7 April 2016) (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>);</LI>
<LI>MEDLINE Ovid (1946 to 7 April 2016) (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>);</LI>
<LI>Embase Ovid (1980 to 7 April 2016) (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>);</LI>
<LI>LILACS BIREME Virtual Health Library (Latin American and Caribbean Health Science Information database; from 1982 to 7 April 2016) (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>);</LI>
<LI>BBO BIREME Virtual Health Library (Bibliografia Brasileira de Odontologia; from 1986 to 7 April 2016) (<LINK REF="APP-05" TYPE="APPENDIX">Appendix 5</LINK>);</LI>
<LI>SciELO Web of Science (from 1997 to 7 April 2016) (<LINK REF="APP-06" TYPE="APPENDIX">Appendix 6</LINK>).</LI>
</UL>
<P>No restrictions were placed on the language or date of publication when searching the electronic databases.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2016-07-26 11:59:54 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the following trial registries for ongoing studies:</P>
<UL>
<LI>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<A HREF="http://www.clinicaltrials.gov">www.clinicaltrials.gov</A>; searched 7 April 2016) (<LINK REF="APP-07" TYPE="APPENDIX">Appendix 7</LINK>);</LI>
<LI>World Health Organization International Clinical Trials Registry Platform (<A HREF="http://apps.who.int/trialsearch">apps.who.int/trialsearch</A>; searched 7 April 2016) (<LINK REF="APP-08" TYPE="APPENDIX">Appendix 8</LINK>).</LI>
</UL>
<P>References from original papers and review articles were cross-checked to identify additional trials and no further randomised controlled trials were found.</P>
<P>We contacted first authors of randomised controlled trials and specialists to identify further information about unpublished studies.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2016-10-03 22:12:49 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<STUDY_SELECTION MODIFIED="2016-07-26 12:03:54 +0100" MODIFIED_BY="[Empty name]">
<P>Four review authors (Fernando Rodrigues Carvalho (FRC), Debora Lentini-Oliveira (DLO), Lucila Fernandes Prado (LFP), and Gilmar Fernandes Prado (GFP)) scanned the titles and abstracts of all reports identified through the searches. Full reports were obtained for trials appearing to meet the inclusion criteria or for which there was insufficient information in the title and abstract to make a clear decision. Full reports obtained were assessed independently, in duplicate, by two review authors (FRC and DLO) to establish whether the trials met the inclusion criteria or not. Disagreements were resolved by discussion with the main supervisor (Luciane Bizari Carvalho (LBC)).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2016-07-26 12:04:47 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors (FRC and DLO) extracted data independently using specially designed data extraction forms. The date of the study, year of publication, setting and funding source of trials, sample size, age (mean or range, or both) and gender of participants, types of interventions, duration of study and tolerability were recorded.<BR/>The characteristics of the trial participants, interventions and outcomes for the included trial are presented in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table.<BR/>We contacted study authors for clarification or for further information.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2016-07-26 14:29:59 +0100" MODIFIED_BY="[Empty name]">
<P>The quality assessment of the included trial was undertaken independently and in duplicate by two review authors (FRC and DLO) as part of the data extraction process. If there was uncertainty, the main supervisor (LBC) was consulted.</P>
<P>We used Cochrane's tool for assessing risk of bias as outlined in the <I>Cochrane Handbook for</I> <I>Systematic Reviews of Interventions</I> Version 5.1.0 (updated March 2011) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>We examined seven domains:</P>
<OL>
<LI>sequence generation,</LI>
<LI>allocation sequence concealment,</LI>
<LI>blinding of participants/personnel,</LI>
<LI>blinding of outcome assessment,</LI>
<LI>incomplete outcome data,</LI>
<LI>selective outcome reporting,</LI>
<LI>other bias (balance of baseline characteristics, free from co-intervention).</LI>
</OL>
<P>Each domain included one or more specific entries in a 'Risk of bias' table. Within each entry, we described information reported in the study and assigned a judgement relating to the risk of bias for that entry. Where the study clearly reported the methodology, we made a judgement of low risk of bias or high risk of bias. Where trial methodology was unclear, we judged a domain as at unclear risk of bias. We tried to get more information from the study authors. When we were provided with additional information, we re-assessed the overall risk of bias in included trials over all seven domains.</P>
<P>We categorised the overall risk of bias of individual studies according to the following criteria:</P>
<UL>
<LI>low risk of bias (plausible bias unlikely to seriously alter the results; all seven domains assessed as at low risk of bias),</LI>
<LI>high risk of bias (plausible bias that seriously weakens confidence in the results; at least one domain assessed as at high risk of bias),</LI>
<LI>unclear risk of bias (plausible bias that raises some doubt about the results; at least one domain assessed as at unclear risk of bias, but none at high risk of bias).</LI>
</UL>
<P>We also presented the risk of bias summary graphically (<LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2016-07-26 12:20:03 +0100" MODIFIED_BY="[Empty name]">
<P>We calculated risk ratios, the number needed to treat and corresponding 95% confidence intervals for dichotomous data and expressed them by individual study. In cases where the included studies presented results as continuous data, we would have expressed the results as mean difference and 95% confidence intervals. For both continuous and dichotomous data we would have carried out a meta-analysis when possible and appropriate.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2016-10-03 15:57:28 +0100" MODIFIED_BY="[Empty name]">
<P>Trials with multiple treatment arms: For trials with more than one intervention group and a common control group (placebo or no intervention) we would have tried to use the partial data, only data from relevant group and control group.</P>
<P>Cross-over studies were not felt to be an appropriate study design for this research question due to potential carry over effects of the first treatment.<BR/>
</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2016-07-26 13:38:30 +0100" MODIFIED_BY="[Empty name]">
<P>We attempted to contact the author(s) of included studies, where feasible, for clarification, missing data, and details of any other outcomes that may have been measured but not reported.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2016-10-03 15:58:00 +0100" MODIFIED_BY="[Empty name]">
<P>The significance of discrepancies in the estimates of treatment effects from the different trials would have been assessed by the I<SUP>2</SUP> statistic and classified according to the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). A guide to interpretation of the I<SUP>2</SUP> statistic is as follows:</P>
<UL>
<LI>0% to 40% might not be important,</LI>
<LI>30% to 60% may represent moderate heterogeneity,</LI>
<LI>50% to 90% may represent substantial heterogeneity,</LI>
<LI>75% to 100% very substantial (considerable) heterogeneity.</LI>
</UL>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2016-10-03 16:02:56 +0100" MODIFIED_BY="[Empty name]">
<P>Within-study reporting bias, it is one of the seven domains of the Risk of bias as 'selective outcome reporting'. It would ideally be assessed by comparing the outcomes in the paper published against the study protocol. As it is not possible in most cases, we compared the outcomes referred in the methods with the results showed. If the outcome were listed in the methods but not reported, we try to get more information from authors of the study, then we judge this as 'high risk' or 'low risk' of bias or 'unclear' (insufficient information to judge the risk of bias).</P>
<P>If possible, publication bias would have been assessed by plotting data onto a funnel graph (trial effect versus trial size) (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). However, this was not feasible due to the inclusion of only one study.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2016-10-03 16:07:25 +0100" MODIFIED_BY="[Empty name]">
<P>For the included trial, risk ratios with 95% confidence intervals were calculated for all important dichotomous outcomes.</P>
<P>If further studies are included in future updates, we will carry out meta-analyses where there are studies of similar comparisons reporting the same outcomes. We would combine mean differences for continuous data, and risk ratios for dichotomous data. Our general approach would be to use a random-effects model. With this approach, the CIs for the average intervention effect would be wider than those that would be obtained using a fixed-effect approach, leading to a more conservative interpretation.</P>
<P>We would use additional tables to report the results from studies not suitable for inclusion in a meta-analysis.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2016-07-26 14:10:04 +0100" MODIFIED_BY="[Empty name]">
<P>A subgroup analysis would have been carried out comparing studies that included different ranges of participants' age, but there were insufficient trials to undertake this.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2016-10-03 22:12:49 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Sensitivity analyses would have been performed according to the risk of bias assessments of the included studies. If there had been an adequate number of studies, quasi-randomised studies would also have been analysed separately from the randomised ones in a sensitivity analysis. However, as there was only one study included in the review, no sensitivity analyses were carried out.</P>
<SUBSECTION>
<HEADING LEVEL="3">Presentation of main results</HEADING>
<P>We established a 'Summary of findings' table using the following outcomes listed according to priority.</P>
<OL>
<LI>Apnoea-hypopnoea index (AHI) (assessed with polysomnography).</LI>
<LI>Daytime symptoms: sleepiness (assessed with Brouillette questionnaire).</LI>
<LI>Daytime symptoms: irritability (assessed with Brouillette questionnaire).</LI>
<LI>Daytime symptoms: tiredness (assessed with Brouillette questionnaire).</LI>
<LI>Daytime symptoms: school problems (assessed with Brouillette questionnaire).</LI>
<LI>Daytime symptoms: morning headache (assessed with Brouillette questionnaire).</LI>
<LI>Daytime symptoms: oral breathing (assessed with Brouillette questionnaire).</LI>
</OL>
</SUBSECTION>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2016-10-03 22:11:53 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<STUDY_DESCRIPTION MODIFIED="2016-10-03 22:11:53 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<SEARCH_RESULTS MODIFIED="2016-07-26 15:35:07 +0100" MODIFIED_BY="[Empty name]">
<P>We identified a total of 686 potentially relevant records by electronic searching. Six hundred and seventy-nine records were discarded as not relevant for this review after assessment of the titles and abstracts. After obtaining the full texts, we excluded three studies (five records) (<LINK REF="STD-Ghodke-2014" TYPE="STUDY">Ghodke 2014</LINK>; <LINK REF="STD-Guilleminault-2011" TYPE="STUDY">Guilleminault 2011</LINK>; <LINK REF="STD-Nunes-2011" TYPE="STUDY">Nunes 2011</LINK>) and included one study (two records) (<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK>). We are not aware of any ongoing study.</P>
<P>We used the full search conducted as described in the <LINK TAG="SEARCH_METHODS" TYPE="SECTION">Search methods for identification of studies</LINK> section on 7 April 2016 to construct the PRISMA flow chart shown as <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<P>Summary details are given in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> tables.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2016-10-03 22:11:53 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>
<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> is a quasi-randomised controlled trial conducted in Italy during six months. Randomisation was assigned alphabetically, by surname.</P>
<P>Thirty-two children, 20 male and 12 female, with an age range of 4 to 10 years (mean 7.1 +/- 2.6 years), with apnoea index (defined as the number of apnoeas per hour of total sleep time) of more than one event per hour diagnosed by polysomnography and who had evident clinical signs of dysgnathia participated in this study.</P>
<P>
<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> compared a personalised active oral appliance to no treatment. Email correspondence with the study authors confirmed that the participants were fitted the oral appliance at the time of the second polysomnography.</P>
<P>The parents of all participants completed a modified version of the Brouillette questionnaire on the daytime and night-time symptoms before the trial and after six months. The answers of the questionnaire range from 0 to 4 points and they were considered an improvement when the answers fell at least two points, after six months.<BR/>
</P>
<P>The outcomes measured included apnoea-hypopnoea index measured by polysomnography; daytime symptoms: sleepiness, irritability, tiredness, school problems, morning headache, thirstiness in the morning, oral breathing and nasal stuffiness measured by questionnaire; and night-time symptoms: habitual snoring, restless sleep and nightmares measured by questionnaire.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2016-07-26 15:40:43 +0100" MODIFIED_BY="[Empty name]">
<P>Three studies did not meet the inclusion criteria and they were excluded. The main reasons for exclusion were:<BR/>
</P>
<UL>
<LI>polysomnography not used to evaluate sleep (two studies),</LI>
<LI>study compared an oral appliance to surgery without placebo or no treatment group (one study).</LI>
</UL>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2016-10-03 16:13:34 +0100" MODIFIED_BY="[Empty name]">
<ALLOCATION MODIFIED="2016-10-03 16:13:34 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Sequence generation</HEADING>
<P>The included trial (<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK>) used a quasi-random method of allocation, alphabetically by surname, and was assessed at high risk of selection bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>
<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> did not report any information about allocation concealment, but the poor randomisation method used would have made adequate allocation concealment impossible in this trial. It was therefore assessed at high risk of bias for this domain.</P>
</SUBSECTION>
</ALLOCATION>
<BLINDING MODIFIED="2016-07-26 20:58:11 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>In <LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> it was impossible to blind the participants because the intervention group wore an oral appliance whilst the control or no treatment group wore nothing and could easily be distinguished from the active intervention. We assessed the study at high risk of performance bias.</P>
<P>Blinding of outcome assessment was not reported, therefore we assessed the study at unclear risk of detection bias.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2016-07-26 21:10:09 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>We assessed <LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> at high risk of attrition bias due to the high percentage of participants lost to follow-up: five (26.3%) participants in the treatment group and four (30.8%) participants in the control group. The reasons for dropouts within the treatment group were described: one child found the oral appliance intolerable, two children lost their appliances three times and then refused to wear them again and two children found wearing the oral appliance at school embarrassing and discontinued therapy.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2016-07-26 21:23:06 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Ideally we would have compared the outcomes listed in each study protocol with the outcomes reported in the papers, but since this was impossible, we then compared the results reported in the included study against those listed in the methods section. We assessed <LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> at low risk of reporting bias, because the outcomes reported in the results section were all those listed in the methods.<BR/>
</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2016-07-26 21:30:17 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<SUBSECTION>
<HEADING LEVEL="4">Balance of baseline characteristics and free from co-intervention</HEADING>
<P>The study authors reported that there were no differences between groups at baseline but there is no analysis to support this. The study authors did not report any other interventions during the same treatment time. We therefore assessed the included study at unclear risk of other bias.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Overall risk of bias</HEADING>
<P>A summary of the risk of bias assessments for each domain is shown in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> . The included trial in this review was assessed at high risk of bias.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2016-10-03 22:09:50 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Meta-analyses were originally planned, but they were not possible since only one study was included (<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK>).</P>
<P>It has not been possible to fully achieve the objectives of this review as there is a lack of trials in this area. The included trial (<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK>) compared a personalised active oral appliance to no treatment and helped us to answer four secondary outcomes: reduction of apnoea episodes measured by standard polysomnography; daytime and nocturnal symptoms e.g. daytime sleepiness, behavioural problems, nightmares and side effects - tolerability - measured by patient's self report.</P>
<P>We calculated risk ratios (RRs) with 95% confidence intervals (CIs) for all dichotomous data as planned.<BR/>We found statistically significant differences in the following results: reduction of the apnoea-hypopnoea index measured by polysomnography; daytime symptoms measured by questionnaire: oral breathing and nasal stuffiness; and night-time symptoms measured by questionnaire: habitual snoring and restless sleep.<BR/>All outcomes and results are described below.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Reduction to less than one episode of apnoea per hour measured by standard polysomnography</HEADING>
<P>A decrease of at least 50% in the apnoea/hypopnoea index (AHI) was considered in this study (<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK>) as treatment success. In 9 of the 14 treated subjects (62.4%) the AHI fell 50%. <LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> showed the apnoea index only in the oral appliance group before (7.1 +/- 4.6) and after (2.6 +/- 2.2) the treatment as mean values and standard deviation. It proved impossible to know how many patients had apnoea index &lt; 1 (primary outcome).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">(1) Reduction of apnoea episodes measured by standard polysomnography</HEADING>
<P>Results from the paper can be found in Additional <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<P>Results from our analysis: RR = 0.39, 95% CI 0.20 to 0.76, P = 0.006, favouring treatment (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), but result is from a study with very low quality of evidence for this outcome (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Reduction of upper airway resistance syndrome (UARS) measured by standard polysomnography and body-weight development curve compared by graphic of body mass index for age percentiles</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Reduction of snoring measured by standard polysomnography</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Signs and symptoms of respiratory disease: mouth breathing, nasal airway resistance measured by clinical assessment or rhinomanometry or fibroscopy</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Signs and symptoms of atypical swallowing, and speech production disturbance measured by validated tests for speech production or videofluoroscopy or clinical assessment</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Daytime and nocturnal symptoms</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Daytime symptoms (measured by questionnaire)</HEADING>
<P>Results from the paper are presented in Additional <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK> and <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>.</P>
<P>Results from our analysis.</P>
<UL>
<LI>Sleepiness: RR = 0.64, 95% CI 0.11 to 3.78 (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>), non-significant result (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</LI>
<LI>Irritability: RR = 0.32, 95% CI 0.07 to 1.41 (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>), non-significant result (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</LI>
<LI>Tiredness: RR = 0.26, 95% CI 0.06 to 1.05 (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), non-significant result (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</LI>
<LI>School problems: RR = 0.64, 95% CI 0.11 to 3.78 (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>), non-significant result (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</LI>
<LI>Morning headache: RR = 0.39, 95% CI 0.12 to 1.23 (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>), non-significant result (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</LI>
<LI>Thirsty in the morning: RR = 0.16, 95% CI 0.02 to 1.22 (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>), non-significant result.</LI>
<LI>Oral breathing: RR = 0.16, 95% CI 0.04 to 0.59, P = 0.006 (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>), favouring treatment, but result is from a study with very low quality of evidence for this outcome (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</LI>
<LI>Nasal stuffiness: RR = 0.18, 95% CI 0.05 to 0.69, P = 0.01 (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>), favouring treatment, but result is from a study with very low quality of evidence.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Nocturnal symptoms (measured by questionnaire)</HEADING>
<P>Results from the paper are presented in Additional <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK> and <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>.</P>
<P>Results from our analysis.</P>
<UL>
<LI>Habitual snoring: RR = 0.18, 95% CI 0.06 to 0.55, P = 0.003 (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>), favouring treatment, but result is from a study with very low quality of evidence.</LI>
<LI>Restless sleep: RR = 0.21, 95% CI 0.05 to 0.84, P = 0.03 (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>), favouring treatment, but result is from a study with very low quality of evidence.</LI>
<LI>Nightmares: RR = 0.22, 95% CI 0.01 to 4.93 (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>), non-significant result.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Change of mandibular length measured by cephalometric data</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(8) Improvement on sagittal relationship between the maxilla-mandible measured by cephalometric data</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(9) Changes of the width between cuspids and first molars measured by plaster models</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(10) Change of the arch perimeter measured by plaster models</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(11) Improvement of the overbite and overjet measured by plaster models</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(12) Alteration of growth pattern measured in cephalometric data or facial analysis</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(13) Quality of life measured by validated scale</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(14) Side effects - tolerability - measured by patient's self report</HEADING>
<P>Side effects: the included study did not assess this outcome.</P>
<P>Tolerability: 73.7% fitted with oral appliance (14/19 children) tolerated the treatment well and 26.3% (five children) discontinued therapy (two preferred not to wear the oral appliance, two lost their appliances three times and then refused to wear them again and one did not tolerate it).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(15) Economic evaluation - costs</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(16) Educational outcomes: cognitive function measured by validated scale</HEADING>
<P>The included study did not assess this outcome.</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2016-10-03 22:29:50 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<SUMMARY_OF_RESULTS MODIFIED="2016-07-27 10:59:43 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>The main aim of this review was to estimate the effects of the use of oral appliances or functional appliances for treating obstructive sleep apnoea in children compared to placebo or no treatment. We found no new studies for inclusion in this update, so <LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> remains as the only included study in the review.</P>
<P>
<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> compared an oral appliance to no treatment and presented results analysing each group before and after six months follow-up. It found favourable results in the treated group for apnoea/hypopnoea index, night-time symptoms (habitual snoring, restless sleep) and daytime symptoms (sleepiness, irritability, tiredness, thirstiness in the morning, oral breathing, nasal stuffiness) (Additional <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>; <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>; <LINK REF="TBL-03" TYPE="TABLE">Table 3</LINK>; <LINK REF="TBL-04" TYPE="TABLE">Table 4</LINK>; <LINK REF="TBL-05" TYPE="TABLE">Table 5</LINK>). When we compared the two groups at six months, the results were not as favourable as those presented in the original study. We found favourable results in the treated group for apnoea/hypopnoea index, night-time symptoms (habitual snoring, restless sleep) and daytime symptoms (oral breathing, nasal stuffiness) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>; <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>; <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>; <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>; <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>; <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>).</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2016-07-22 18:04:29 +0100" MODIFIED_BY="[Empty name]">
<P>Unfortunately, the available information from one study (<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK>) with very low quality of evidence, is not enough to answer whether oral appliances or functional orthopaedic appliances are effective in the treatment of sleep apnoea in children.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2016-10-03 22:29:50 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>
<LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> was the single study included and although it showed some results that favoured the intervention, it must be considered with caution due to methodological problems such as a non-randomised generation of allocation, no allocation concealment, no blinding, no sample size calculation reported, the number of patients randomised was different from patients analysed, high number of losses to follow-up and no intention-to-treat analysis. <LINK REF="STD-Villa-2002" TYPE="STUDY">Villa 2002</LINK> was therefore assessed as at high risk of bias and of very low-quality evidence (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<P>There is an important methodological problem we found with many studies not showing important information necessary to assess their quality. Papers did not present information such as how participants were allocated to interventions, who generated the allocation, how sample size was determined, etc. Therefore it is important that all authors follow the Consolidated Standards of Reporting Trials (CONSORT) guidelines when designing and reporting trials (<LINK REF="REF-Begg-1996" TYPE="REFERENCE">Begg 1996</LINK>; <LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2016-07-27 11:03:22 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>We conducted a sensitive search strategy of multiple databases to identify suitable studies for this review, with no restrictions on language, publication status, date or source of information. We attempted to contact some study authors for missing information, however, we could not find more studies, and some authors did not respond. We could not get all the necessary information to clarify our judgements of unclear or high risk of bias. Therefore, authors of the included study are encouraged to contact us to clarify these points. For future updates, we would also appreciate any information regarding unpublished or ongoing studies that we may not have identified.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2016-07-27 11:22:05 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>The aim of this systematic review was to assess the effects of oral appliances and functional orthopaedic appliances in the treatment of obstructive sleep apnoea in children when compared to placebo or no treatment. There is a clinical trial (<LINK REF="REF-Guilleminault-2008" TYPE="REFERENCE">Guilleminault 2008</LINK>) whose participants were children with adenotonsillar hypertrophy and malocclusion that concluded that for most of the children, the two proposed treatments were needed (intraoral appliance and adeno-tonsillectomy) independently of which treatment was done first, but one treatment would complement the other in resolving obstructive sleep apnoea.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2016-10-03 22:31:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<IMPLICATIONS_PRACTICE MODIFIED="2016-10-03 22:31:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Despite a thorough search for evidence relating to the effects of treatment with oral appliances or functional orthopaedic appliances for obstructive sleep apnoea in children, very low-quality evidence was found, but it must be interpreted as 'very low evidence of effect' and not as 'evidence of very low effect'. At present there is not enough evidence to affirm that oral appliances and functional orthopaedic appliances are effective in the treatment of obstructive sleep apnoea in children. Oral appliances or functional orthopaedic appliances may be considered in specified cases as an auxiliary in the treatment of children who have craniofacial anomalies which are risk factors for apnoea.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2016-07-27 11:36:04 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>We suggest that clinical trials on malocclusion problems or respiratory disease should include information and results about how to improve respiratory and malocclusion problems. It is important that dentists look for any respiratory problems when treating a malocclusion because they can be treating respiratory problems without knowing, or when they diminish the oral space they can be promoting the tongue to fall into the oropharynx and cause obstructive sleep apnoea, or they can face difficulties when treating some malocclusion because there is a respiratory problem associated. It is also important that physicians treating respiratory problems look for malocclusion problems, because some respiratory problems can return if the malocclusion problem is not solved.</P>
<P>Clinical trials must have well established the objective of the research. It will be make a difference when the results are interpreted. If the objective is only a palliative or immediate care to diminish the apnoea index, the oral appliance can be indicated because it will change the mandibular position forwards and enlarge the upper airway space. The polysomnography to assess the results can be made after a short period of time that the oral appliance has been fitted, and at the moment of the polysomnography the oral appliance must be in the mouth. But if the objective is to treat and cure with the use of the oral appliance that not only will change the mandibular position forwards and enlarge the upper airway but also promote dento-alveolar and skeletal growth, the polysomnography to assess the results must be made after a longer period of time and the oral appliance must not be in the mouth.</P>
<P>Good quality randomised controlled trials that involve a representative number of patients with apnoea and malocclusion are necessary to answer the principal question of this systematic review: are oral appliances or functional orthopaedic appliances an effective treatment for obstructive sleep apnoea in children.</P>
<P>Reporting of clinical trials could be improved adopting the Consolidated Standards of Reporting Trials (CONSORT) statement (<LINK REF="REF-Begg-1996" TYPE="REFERENCE">Begg 1996</LINK>; <LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>) to ensure that all relevant information is provided.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2016-07-26 23:26:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Cochrane Oral Health, especially Luisa M Fernandez Mauleffinch and Anne Littlewood.<BR/>Brazilian Cochrane Center.<BR/>MAC Machado and H Saconato for their contribution to the previous version of this review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2016-07-25 15:50:05 +0100" MODIFIED_BY="[Empty name]">
<P>Fernando R Carvalho: none known.<BR/>Débora A Lentini-Oliveira: none known.<BR/>Lucila BF Prado: none known.<BR/>Gilmar F Prado: none known.<BR/>Luciane BC Carvalho: none known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2016-07-26 23:21:46 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Fernando Rodrigues Carvalho: review conception and design, study selection, data extraction, analysis and interpretation of data, quality assessment.<BR/>Debora Aparecida Lentini-Oliveira: quality assessment, study selection, data extraction, data analysis.<BR/>Gilmar Fernandes Prado: study selection.<BR/>Lucila Bizari Fernandes Prado: study selection.<BR/>Luciane Bizari Coin Carvalho: quality assessment, data analysis, methodological supervisor.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2016-07-26 23:23:00 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Methods have been updated.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2016-11-01 11:05:11 +0000" MODIFIED_BY="[Empty name]">
<P>This review will not be updated until a substantial body of evidence on the topic becomes available. If trials are conducted and found eligible for inclusion in the future, the review would then be updated accordingly.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2016-11-01 11:06:18 +0000" MODIFIED_BY="Luisa Fernandez Mauleffinch">
<STUDIES MODIFIED="2016-07-25 14:07:06 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2016-07-25 13:23:28 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Villa-2002" MODIFIED="2016-07-25 13:23:28 +0100" MODIFIED_BY="[Empty name]" NAME="Villa 2002" YEAR="2002">
<REFERENCE MODIFIED="2016-07-25 13:23:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Villa M, Bernkopf E, Pagani J, Barreto M, Broia V, Massa F, et al</AU>
<TI>An oral appliance for the treatment of obstructive sleep apnea in children</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2000</YR>
<VL>161</VL>
<NO>3 (Suppl)</NO>
<PG>A27</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4391187"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-06-11 17:16:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Villa MP, Bernkopf E, Pagani J, Broia V, Montesano M, Ronchetti R</AU>
<TI>Randomized controlled study of an oral jaw-positioning appliance for the treatment of obstructive sleep apnea in children with malocclusion</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2002</YR>
<VL>165</VL>
<NO>1</NO>
<PG>123-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="2918898"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="2918897"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2016-07-25 14:07:06 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ghodke-2014" MODIFIED="2016-07-25 13:52:58 +0100" MODIFIED_BY="[Empty name]" NAME="Ghodke 2014" YEAR="2014">
<REFERENCE MODIFIED="2016-07-25 13:52:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghodke S, Utreja AK, Singh SP, Jena AK</AU>
<TI>Effects of twin-block appliance on the anatomy of pharyngeal airway passage (PAP) in class II malocclusion subjects</TI>
<SO>Progress in Orthodontics</SO>
<YR>2014</YR>
<VL>15</VL>
<PG>68</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4391189"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-06-04 18:56:20 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4391188"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guilleminault-2011" MODIFIED="2016-07-25 13:48:07 +0100" MODIFIED_BY="[Empty name]" NAME="Guilleminault 2011" YEAR="2011">
<REFERENCE MODIFIED="2016-07-25 13:46:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Guilleminault C, Monteyrol PJ, Huynh NT, Pirelli P, Quo S, Li K</AU>
<TI>Adeno-tonsillectomy and rapid maxillary distraction in pre-pubertal children, a pilot study</TI>
<SO>Sleep &amp; Breathing</SO>
<YR>2011</YR>
<VL>15</VL>
<NO>2</NO>
<PG>173-7</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4391191"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-25 13:48:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Guilleminault C, Quo S, Huynh NT, Li K</AU>
<TI>Orthodontic expansion treatment and adenotonsillectomy in the treatment of obstructive sleep apnea in prepubertal children</TI>
<SO>Sleep</SO>
<YR>2008</YR>
<VL>31</VL>
<NO>7</NO>
<PG>953-7 [Erratum Sleep 2009;1;32(1):table of contents] [Retraction Sleep 2010;33(1):8]</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4391192"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4391190"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nunes-2011" MODIFIED="2016-07-25 14:07:06 +0100" MODIFIED_BY="[Empty name]" NAME="Nunes 2011" YEAR="2012">
<REFERENCE MODIFIED="2016-07-25 14:07:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nunes Junior WR, Di Francesco RC</AU>
<TI>Snoring children treatment with orthodontic and orthopedic appliance - randomized clinical trial</TI>
<SO>Sleep &amp; Breathing</SO>
<YR>2011</YR>
<VL>15</VL>
<NO>2</NO>
<PG>257-8</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4391194"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2016-07-25 14:06:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nunes Junior WR, Francesco-Mion RCD</AU>
<TI>Early treatment and preventive strategies for obstructive sleep apnea and hypopnea with the bioajusta x orthodontic-orthopedic treatment</TI>
<SO>Sleep Medicine</SO>
<YR>2009</YR>
<VL>10 Suppl 2</VL>
<PG>S41-2</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="4391195"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="4391193"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2016-05-26 21:31:10 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2016-05-29 19:30:55 +0100" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2016-07-25 14:28:38 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2016-07-25 14:24:25 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-AAP-Guideline-2002" NAME="AAP Guideline 2002" TYPE="JOURNAL_ARTICLE">
<AU>American Academy of Pediatrics (AAP). Subcommittee on Obstructive Sleep Apnea Syndrome</AU>
<TI>Clinical practice guideline: diagnosis and management of childhood obstructive sleep apnea syndrome</TI>
<SO>Pediatrics</SO>
<YR>2002</YR>
<VL>109</VL>
<NO>4</NO>
<PG>704-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Begg-1996" MODIFIED="2016-06-26 21:01:02 +0100" MODIFIED_BY="[Empty name]" NAME="Begg 1996" TYPE="JOURNAL_ARTICLE">
<AU>Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al</AU>
<TI>Improving the quality of reporting of randomised controlled trials. The CONSORT statement</TI>
<SO>JAMA</SO>
<YR>1996</YR>
<VL>276</VL>
<NO>8</NO>
<PG>637-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bell-2001" NAME="Bell 2001" TYPE="JOURNAL_ARTICLE">
<AU>Bell RB, Turvey TA</AU>
<TI>Skeletal advancement for the treatment of obstructive sleep apnea</TI>
<SO>The Cleft Palate-Craniofacial Journal</SO>
<YR>2001</YR>
<VL>38</VL>
<NO>2</NO>
<PG>147-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brouillette-1982" NAME="Brouillette 1982" TYPE="JOURNAL_ARTICLE">
<AU>Brouillette RT, Fernbach SK, Hunt CE</AU>
<TI>Obstructive sleep apnea in infants and children</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1982</YR>
<VL>100</VL>
<NO>1</NO>
<PG>31-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carroll-1995a" MODIFIED="2016-07-25 14:08:53 +0100" MODIFIED_BY="[Empty name]" NAME="Carroll 1995a" TYPE="BOOK_SECTION">
<AU>Carroll JL, Loughlin GM</AU>
<TI>Obstructive sleep apnea syndrome in infants and children: clinical features and pathophysiology</TI>
<SO>Principles and Practice of Sleep Medicine in the Child</SO>
<YR>1995</YR>
<PG>163-91</PG>
<ED>Ferber R, Kryger M</ED>
<PB>Saunders (WB) Co Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carroll-1995b" MODIFIED="2016-07-25 14:11:55 +0100" MODIFIED_BY="[Empty name]" NAME="Carroll 1995b" TYPE="BOOK_SECTION">
<AU>Carrol JL, Loughlin GM</AU>
<TI>Obstructive sleep apnea syndrome in infants and children: diagnosis and management</TI>
<SO>Principles and Practice of Sleep Medicine in the Child</SO>
<YR>1995</YR>
<PG>193-216</PG>
<ED>Ferber R, Kryger M</ED>
<PB>Saunders (WB) Co Ltd</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carroll-2003" NAME="Carroll 2003" TYPE="JOURNAL_ARTICLE">
<AU>Carroll JL</AU>
<TI>Obstructive sleep disordered breathing in children: new controversies, new directions</TI>
<SO>Clinics in Chest Medicine</SO>
<YR>2003</YR>
<VL>24</VL>
<NO>2</NO>
<PG>261-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carvalho-2014" MODIFIED="2016-07-25 14:15:47 +0100" MODIFIED_BY="[Empty name]" NAME="Carvalho 2014" TYPE="JOURNAL_ARTICLE">
<AU>Carvalho FR, Lentini-Oliveira DA, Carvalho GM, Prado LB, Prado GF, Carvalho LB</AU>
<TI>Sleep-disordered breathing and orthodontic variables in children - Pilot study</TI>
<SO>International Journal of Pediatric Otorhinolaryngology</SO>
<YR>2014</YR>
<VL>78</VL>
<NO>11</NO>
<PG>1965-9</PG>
<IDENTIFIERS MODIFIED="2016-07-25 14:15:47 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-06-26 22:20:30 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1016/j.ijporl.2014.08.040"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chan-2004" NAME="Chan 2004" TYPE="JOURNAL_ARTICLE">
<AU>Chan J, Edman JC, Koltai PJ</AU>
<TI>Obstructive sleep apnea in children</TI>
<SO>American Family Physician</SO>
<YR>2004</YR>
<VL>69</VL>
<NO>5</NO>
<PG>1147-54</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="15023015"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Chervin-1997" NAME="Chervin 1997" TYPE="JOURNAL_ARTICLE">
<AU>Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ</AU>
<TI>Symptoms of sleep disorders, inattention, and hyperactivity in children</TI>
<SO>Sleep</SO>
<YR>1997</YR>
<VL>20</VL>
<NO>12</NO>
<PG>1185-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Defabjanis-2003" NAME="Defabjanis 2003" TYPE="JOURNAL_ARTICLE">
<AU>Defabjanis P</AU>
<TI>Impact of nasal airway obstruction on dentofacial development and sleep disturbances in children: preliminary notes</TI>
<SO>Journal of Clinical Pediatric Dentistry</SO>
<YR>2003</YR>
<VL>27</VL>
<NO>2</NO>
<PG>95-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Goldstein-2000" NAME="Goldstein 2000" TYPE="JOURNAL_ARTICLE">
<AU>Goldstein NA, Post JC, Rosenfeld RM, Campbell TF</AU>
<TI>Impact of tonsillectomy and adenoidectomy on child behavior</TI>
<SO>Archives of Otolaryngology Head &amp; Neck Surgery</SO>
<YR>2000</YR>
<VL>126</VL>
<NO>4</NO>
<PG>494-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guilleminault-1989" NAME="Guilleminault 1989" TYPE="JOURNAL_ARTICLE">
<AU>Guilleminault C, Partinen M, Praud JP, Quera-Salva MA, Powell N, Riley R</AU>
<TI>Morphometric facial changes and obstructive sleep apnea in adolescents</TI>
<SO>The Journal of Pediatrics</SO>
<YR>1989</YR>
<VL>114</VL>
<NO>6</NO>
<PG>997-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guilleminault-1990" NAME="Guilleminault 1990" TYPE="JOURNAL_ARTICLE">
<AU>Guilleminault C, Stoohs R</AU>
<TI>Chronic snoring and obstructive sleep apnea syndrome in children</TI>
<SO>Lung</SO>
<YR>1990</YR>
<VL>168 Suppl</VL>
<PG>912-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Guilleminault-2008" MODIFIED="2016-07-25 14:18:12 +0100" MODIFIED_BY="[Empty name]" NAME="Guilleminault 2008" TYPE="JOURNAL_ARTICLE">
<AU>Guilleminault C, Quo S, Huynh NT, Li K</AU>
<TI>Orthodontic expansion treatment and adenotonsillectomy in the treatment of obstructive sleep apnea in prepubertal children</TI>
<SO>Sleep</SO>
<YR>2008</YR>
<VL>31</VL>
<NO>7</NO>
<PG>953-7 [Erratum Sleep 2009;32(1):table of contents], [Retraction Sleep 2010;33(1):8]</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2016-07-25 14:21:09 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JP, Green S, editor(s)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<MD>Available from www.cochrane-handbook.org</MD>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kheirandish_x002d_Gozal-2006" MODIFIED="2016-06-26 21:00:12 +0100" MODIFIED_BY="[Empty name]" NAME="Kheirandish-Gozal 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kheirandish-Gozal L, Capdevila OS, Tauman R, Gozal D</AU>
<TI>Plasma C-reactive protein in non obese children with obstructive sleep apnea before and after adenotonsillectomy</TI>
<SO>Journal of Clinical Sleep Medicine</SO>
<YR>2006</YR>
<VL>2</VL>
<NO>3</NO>
<PG>301-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kohler-2008" MODIFIED="2016-07-25 14:22:25 +0100" MODIFIED_BY="[Empty name]" NAME="Kohler 2008" TYPE="JOURNAL_ARTICLE">
<AU>Kohler M, Lushington K, Couper R, Martin J, Heuvel C, Pamula Y, et al</AU>
<TI>Obesity and risk of sleep related upper airway obstruction in caucasian children</TI>
<SO>Journal of Clinical Sleep Medicine</SO>
<YR>2008</YR>
<VL>4</VL>
<NO>2</NO>
<PG>130-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marcus-1992" MODIFIED="2016-07-25 14:22:46 +0100" MODIFIED_BY="[Empty name]" NAME="Marcus 1992" TYPE="JOURNAL_ARTICLE">
<AU>Marcus CL, Omlin KJ, Basinki DJ, Bailey SL, Rachal AB, Von Pechmann WS, et al</AU>
<TI>Normal polysomnographic values for children and adolescents</TI>
<SO>The American Review of Respiratory Disease</SO>
<YR>1992</YR>
<VL>146</VL>
<NO>5 Pt 1</NO>
<PG>1235-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marcus-2001" NAME="Marcus 2001" TYPE="JOURNAL_ARTICLE">
<AU>Marcus CL</AU>
<TI>Sleep-disordered breathing in children</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>164</VL>
<NO>1</NO>
<PG>16-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marcus-2012" MODIFIED="2016-07-25 14:23:06 +0100" MODIFIED_BY="[Empty name]" NAME="Marcus 2012" TYPE="JOURNAL_ARTICLE">
<AU>Marcus CL, Brooks LJ, Draper KA, Gozal D, Halbower AC, Jones J, et al</AU>
<TI>Diagnosis and management of childhood obstructive sleep apnea syndrome</TI>
<SO>Pediatrics</SO>
<YR>2012</YR>
<VL>130</VL>
<NO>3</NO>
<PG>e714-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<NO>9263</NO>
<PG>1191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nixon-2005" NAME="Nixon 2005" TYPE="JOURNAL_ARTICLE">
<AU>Nixon GM, Brouillette RT</AU>
<TI>Sleep. 8: Paediatric obstructive sleep apnoea</TI>
<SO>Thorax</SO>
<YR>2005</YR>
<VL>60</VL>
<NO>6</NO>
<PG>511-6</PG>
<IDENTIFIERS><IDENTIFIER TYPE="MEDLINE" VALUE="15923253"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schechter-2002" NAME="Schechter 2002" TYPE="JOURNAL_ARTICLE">
<AU>Schechter MS</AU>
<TI>Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome</TI>
<SO>Pediatrics</SO>
<YR>2002</YR>
<VL>109</VL>
<NO>4</NO>
<PG>e69</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Shintani-1998" NAME="Shintani 1998" TYPE="JOURNAL_ARTICLE">
<AU>Shintani T, Asakura K, Kataura A</AU>
<TI>The effect of adenotonsillectomy in children with OSA</TI>
<SO>International Journal of Pediatric Otorhinolaryngology</SO>
<YR>1998</YR>
<VL>44</VL>
<NO>1</NO>
<PG>51-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tarasiuk-2007" MODIFIED="2016-07-25 14:24:25 +0100" MODIFIED_BY="[Empty name]" NAME="Tarasiuk 2007" TYPE="JOURNAL_ARTICLE">
<AU>Tarasiuk A, Greenberg-Dotan S, Simon-Tuval T, Freidman B, Goldbart AD, Tal A, et al</AU>
<TI>Elevated morbidity and health care use in children with obstructive sleep apnea syndrome</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2007</YR>
<VL>175</VL>
<NO>1</NO>
<PG>55-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Uliel-2004" NAME="Uliel 2004" TYPE="JOURNAL_ARTICLE">
<AU>Uliel S, Tauman R, Greenfeld M, Sivan Y</AU>
<TI>Normal polysomnographic respiratory values in children and adolescents</TI>
<SO>Chest</SO>
<YR>2004</YR>
<VL>125</VL>
<NO>3</NO>
<PG>872-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Viva-1992" NAME="Viva 1992" TYPE="JOURNAL_ARTICLE">
<AU>Viva E, Stefini S, Annibale G, Pedercini R, Zucconi M, Strambi LF</AU>
<TI>Aspects of prevention of obstructive sleep apnea syndrome in developing children</TI>
<SO>Advances in Otorhinolaryngology</SO>
<YR>1992</YR>
<VL>47</VL>
<PG>284-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ward-1996" NAME="Ward 1996" TYPE="JOURNAL_ARTICLE">
<AU>Ward SL, Marcus CL</AU>
<TI>Obstructive sleep apnea in infants and young children</TI>
<SO>Journal of Clinical Neurophysiology</SO>
<YR>1996</YR>
<VL>13</VL>
<NO>3</NO>
<PG>198-207</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2016-07-25 14:28:38 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Carvalho-2005" MODIFIED="2016-07-25 14:28:38 +0100" MODIFIED_BY="[Empty name]" NAME="Carvalho 2005" TYPE="COCHRANE_PROTOCOL">
<AU>Carvalho FR, Lentini-Oliveira DA, Machado MAC, Prado GF, Prado LBF</AU>
<TI>Oral appliances and functional orthopaedics appliances for obstructive sleep apnoea in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2016-07-25 14:28:38 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-07-25 14:28:38 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005520"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Carvalho-2007" MODIFIED="2016-07-25 14:27:12 +0100" MODIFIED_BY="[Empty name]" NAME="Carvalho 2007" TYPE="COCHRANE_REVIEW">
<AU>Carvalho FR, Lentini-Oliveira DA, Machado MAC, Saconato H, Prado LBF, Prado GF</AU>
<TI>Oral appliances and functional orthopaedic appliances for obstructive sleep apnoea in children</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2016-07-25 14:27:12 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-07-25 14:27:12 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005520.pub2"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2016-07-26 23:55:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2016-07-26 23:55:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2016-07-26 23:55:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" STUDY_ID="STD-Villa-2002">
<CHAR_METHODS MODIFIED="2016-07-26 23:44:37 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Trial design: Quasi-randomised, unblinded, prospective study<BR/>Location: Italy</P>
<P>Duration: 6 months</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2016-07-26 23:50:34 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Inclusion criteria: Apnoea index of &gt; 1 event/hour of sleep and dysgnathia (87% participants with deep and retrusive bite and 13% with cross-bite: 86% had deep and retrusive bite and 14% had cross-bite in treated group; 100% had deep and retrusive bite in control group)</P>
<P>Gender: 20 male, 12 female</P>
<P>Age range: 4 to 10 years</P>
<P>Number randomised: 32 (Group 1 = 19; Group 2 = 13)</P>
<P>Number evaluated: 23 (Group 1 = 14; Group 2 = 9).</P>
<P>Dropouts: Group 1 = 5 (2 claimed that they lost their appliances 3 times and then refused to wear them again, 2 children found wearing the oral appliance at school embarrassing and discontinued therapy, and 1 child found the oral appliance intolerable because putting it into the mouth triggered violent, uncontrollable coughing that stopped only when the appliance was removed); Group 2 = 4<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2016-07-25 16:28:29 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison: oral appliance versus no treatment</P>
<P>Group 1: oral appliance (personalised acrylic resin oral bite plate for mandibular positioning)</P>
<P>Group 2: no treatment</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2016-07-26 23:53:29 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>Reduction of apnoea episodes</P>
<P>Daytime symptoms: sleepiness, irritability, tiredness, school problems, morning headache, morning thirstiness, oral breathing and nasal stuffiness<BR/>Night-time symptoms: habitual snoring, restless sleep and nightmares</P>
<P>Tolerability</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2016-07-26 23:55:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<P>We contacted the study author to obtain additional information and although we received new details, they were not sufficient to clarify our judgements of unclear or high risk of bias</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2016-07-26 15:39:40 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2016-07-25 16:15:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghodke-2014">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-25 16:15:57 +0100" MODIFIED_BY="[Empty name]">
<P>No sleep assessment</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-26 15:39:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guilleminault-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-26 15:39:40 +0100" MODIFIED_BY="[Empty name]">
<P>No placebo or no treatment group</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2016-07-25 16:15:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nunes-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2016-07-25 16:15:58 +0100" MODIFIED_BY="[Empty name]">
<P>Study did not use polysomnography to assess sleep</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2016-05-26 21:31:10 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2016-05-29 19:30:55 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2016-07-26 23:32:00 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2016-07-26 23:27:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-26 23:27:14 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="NO" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>Quasi-random method of allocation (alphabetically by surname)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2016-07-26 23:28:06 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-26 23:28:06 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="NO" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>Not reported, but due to the poor randomisation method used it could have been impossible to make an adequate allocation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2016-07-26 11:48:09 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2016-07-26 23:29:52 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2016-07-26 23:29:52 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="NO" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>It was impossible to blind the participants because the intervention group wore an oral appliance and the control group wore nothing and could easily be distinguished from the active intervention; therefore we assessed the study at high risk of performance bias</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2016-07-26 23:30:06 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2016-07-26 23:30:06 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="UNKNOWN" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>Not reported</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2016-07-26 23:30:25 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2016-07-26 23:30:25 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="NO" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>The study lost 5 (26.3%) participants in the treatment group and 4 (30.8%) in the control group</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2016-07-26 23:30:50 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-26 23:30:50 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="YES" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>All outcomes analysed in the results section were reported under methods</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2016-07-26 23:32:00 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2016-07-26 23:32:00 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" RESULT="UNKNOWN" STUDY_ID="STD-Villa-2002">
<DESCRIPTION>
<P>The study authors did not report any other interventions during the same treatment time. The study authors reported that there were no differences between groups at baseline but there is no analysis to support this</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2016-10-03 22:57:27 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<SOF_TABLE ID="SOF-01" MODIFIED="2016-10-03 22:57:27 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="1" READONLY="YES">
<TITLE MODIFIED="2016-07-21 20:30:23 +0100" MODIFIED_BY="[Empty name]">Summary of findings</TITLE>
<TABLE COLS="7" ROWS="20">
<TR>
<TH ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>Oral appliance compared with no treatment for obstructive sleep apnoea in children</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="7" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Patient or population: </B>Children (age range 4 to 10 years old)<BR/>
<B>Setting:</B>
<BR/>
<B>Intervention: </B>Oral appliance<BR/>
<B>Comparison: </B>No treatment</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Anticipated absolute effects<SUP>*</SUP> (95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8470; of participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with no treatment</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>Risk with oral appliance</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Apnoea-hypopnoea index (AHI)<BR/>assessed with polysomnography<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.39<BR/>(0.20 to 0.76)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>1.000 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>390 per 1.000<BR/>(200 to 760)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Daytime symptoms: Sleepiness<BR/>assessed with Brouillette questionnaire (considered improvement a fall of at least 2 points in the score)<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.64<BR/>(0.11 to 3.78)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Change measured with a subjective questionnaire answered by parents</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>222 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>142 per 1.000<BR/>(24 to 840)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Daytime symptoms: Irritability<BR/>assessed with Brouillette questionnaire (considered improvement a fall of at least 2 points in the score)<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.32<BR/>(0.07 to 1.41)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Change measured with a subjective questionnaire answered by parents</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>444 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>142 per 1.000<BR/>(31 to 627)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Daytime symptoms: Tiredness<BR/>assessed with Brouillette questionnaire (considered improvement a fall of at least 2 points in the score)<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.26<BR/>(0.06 to 1.05)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Change measured with a subjective questionnaire answered by parents</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>556 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>144 per 1.000<BR/>(33 to 583)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Daytime symptoms: School problems<BR/>assessed with Brouillette questionnaire (considered improvement a fall of at least 2 points in the score)<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.64<BR/>(0.11 to 3.78)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Change measured with a subjective questionnaire answered by parents</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>222 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>142 per 1.000<BR/>(24 to 840)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Daytime symptoms: Morning headache<BR/>assessed with Brouillette questionnaire (considered improvement a fall of at least 2 points in the score)<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.39<BR/>(0.12 to 1.23)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Change measured with a subjective questionnaire answered by parents</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>556 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>217 per 1.000<BR/>(67 to 683)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Daytime symptoms: Oral breathing<BR/>assessed with Brouillette questionnaire (considered improvement a fall of at least 2 points in the score)<BR/>Follow-up: 6 months</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="2" ROWSPAN="1" VALIGN="TOP">
<P>Study population</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>RR 0.16<BR/>(0.04 to 0.59)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>23<BR/>(1 RCT)</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>&#8853;&#8861;&#8861;&#8861;<BR/>VERY LOW <SUP>1 2 3</SUP>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="2" VALIGN="TOP">
<P>Change measured with a subjective questionnaire answered by parents</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>889 per 1.000</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="1" ROWSPAN="1" VALIGN="TOP">
<P>142 per 1.000<BR/>(36 to 524)</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*<B>The risk in the intervention group</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI)<BR/>
<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; <B>RCT:</B> Randomised controlled trial</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>GRADE Working Group grades of evidence</B>
<BR/>
<B>High quality:</B> We are very confident that the true effect lies close to that of the estimate of the effect<BR/>
<B>Moderate quality:</B> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<BR/>
<B>Low quality:</B> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<BR/>
<B>Very low quality:</B> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Quasi-randomised study, no allocation concealment, no blinding, attrition bias (overall high risk of bias).<BR/>
<SUP>2</SUP> Low sample size and wide confidence interval (imprecision).<BR/>
<SUP>3</SUP> Single, small study (may lack generalisability).<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2016-10-03 22:58:01 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2016-07-26 23:40:17 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="1">
<TITLE MODIFIED="2016-07-26 23:39:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">Apnoea/hypopnoea index - Treated group (from paper)</TITLE>
<TABLE COLS="4" ROWS="2">
<TR>
<TH>
<P>Index</P>
</TH>
<TH>
<P>Baseline mean values</P>
</TH>
<TH>
<P>After 6 months</P>
</TH>
<TH>
<P>P value (Student t)</P>
</TH>
</TR>
<TR>
<TD>
<P>Apnoea/hypopnoea index</P>
</TD>
<TD>
<P>7.1 +/- 4.6</P>
</TD>
<TD>
<P>2.6 +/- 2.2</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Values expressed by mean +/- standard deviation. Student t test before versus after therapy.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2016-10-03 22:57:50 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="2">
<TITLE>Daytime symptoms - Treated group (from paper)</TITLE>
<TABLE COLS="4" ROWS="9">
<TR>
<TH>
<P>Symptoms</P>
</TH>
<TH>
<P>Baseline (n/N)</P>
</TH>
<TH>
<P>After 6 months (n/N)</P>
</TH>
<TH>
<P>P value (Pearson X<SUP>2</SUP>)</P>
</TH>
</TR>
<TR>
<TD>
<P>Sleepiness</P>
</TD>
<TD>
<P>78.6% (11/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>0.002</P>
</TD>
</TR>
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>85.7% (12/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>Tiredness</P>
</TD>
<TD>
<P>78.6% (11/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>0.002</P>
</TD>
</TR>
<TR>
<TD>
<P>School problems</P>
</TD>
<TD>
<P>35.7% (5/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Morning headache</P>
</TD>
<TD>
<P>57.1% (8/14)</P>
</TD>
<TD>
<P>21.4% (3/14)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Thirstiness in the morning</P>
</TD>
<TD>
<P>71.4% (10/14)</P>
</TD>
<TD>
<P>7.1% (1/14)</P>
</TD>
<TD>
<P>0.002</P>
</TD>
</TR>
<TR>
<TD>
<P>Oral breathing</P>
</TD>
<TD>
<P>92.9% (13/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>Nasal stuffiness</P>
</TD>
<TD>
<P>92.9% (13/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>n = number of children with symptom; N = total number of children; NS = non-significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-03" MODIFIED="2016-10-03 22:58:01 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="3">
<TITLE>Daytime symptoms - Control group (from paper)</TITLE>
<TABLE COLS="4" ROWS="9">
<TR>
<TH>
<P>Symptoms</P>
</TH>
<TH>
<P>Baseline (n/N)</P>
</TH>
<TH>
<P>After 6 months (n/N)</P>
</TH>
<TH>
<P>P value (Pearson X<SUP>2</SUP>)</P>
</TH>
</TR>
<TR>
<TD>
<P>Sleepiness</P>
</TD>
<TD>
<P>33.3% (3/9)</P>
</TD>
<TD>
<P>22.2% (2/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Irritability</P>
</TD>
<TD>
<P>44.4% (4/9)</P>
</TD>
<TD>
<P>44.4% (4/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Tiredness</P>
</TD>
<TD>
<P>55.6% (5/9)</P>
</TD>
<TD>
<P>55.6% (5/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>School problems</P>
</TD>
<TD>
<P>22.2% (2/9)</P>
</TD>
<TD>
<P>22.2% (2/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Morning headache</P>
</TD>
<TD>
<P>55.6% (5/9)</P>
</TD>
<TD>
<P>55.6% (5/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Thirstiness in the morning</P>
</TD>
<TD>
<P>55.6% (5/9)</P>
</TD>
<TD>
<P>44.4% (4/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Oral breathing</P>
</TD>
<TD>
<P>100% (9/9)</P>
</TD>
<TD>
<P>88.9% (8/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Nasal stuffiness</P>
</TD>
<TD>
<P>77.8% (7/9)</P>
</TD>
<TD>
<P>77.8% (7/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>n = number of children with symptom; N = total number of children; NS = non-significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-04" MODIFIED="2016-07-26 23:41:47 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="4">
<TITLE>Night-time symptoms - Treated group (from paper)</TITLE>
<TABLE COLS="4" ROWS="4">
<TR>
<TH>
<P>Symptoms</P>
</TH>
<TH>
<P>Baseline (n/N)</P>
</TH>
<TH>
<P>After 6 months (n/N)</P>
</TH>
<TH>
<P>P value (Pearson X<SUP>2</SUP>)</P>
</TH>
</TR>
<TR>
<TD>
<P>Habitual snoring</P>
</TD>
<TD>
<P>92.9% (13/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>Restless sleep</P>
</TD>
<TD>
<P>92.9% (13/14)</P>
</TD>
<TD>
<P>14.3% (2/14)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>28.6% (4/14)</P>
</TD>
<TD>
<P>0% (0/14)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>n = number of children with symptom; N = total number of children; NS = non-significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-05" MODIFIED="2016-07-26 23:42:02 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="5">
<TITLE>Night-time symptoms - Control group (from paper)</TITLE>
<TABLE COLS="4" ROWS="4">
<TR>
<TH>
<P>Symptoms</P>
</TH>
<TH>
<P>Baseline (n/N)</P>
</TH>
<TH>
<P>After 6 months (n/N)</P>
</TH>
<TH>
<P>P value (Pearson X<SUP>2</SUP>)</P>
</TH>
</TR>
<TR>
<TD>
<P>Habitual snoring</P>
</TD>
<TD>
<P>100% (9/9)</P>
</TD>
<TD>
<P>100% (9/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Restless sleep</P>
</TD>
<TD>
<P>66.7% (6/9)</P>
</TD>
<TD>
<P>66.7% (6/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Nightmares</P>
</TD>
<TD>
<P>11.1% (1/9)</P>
</TD>
<TD>
<P>11.1% (1/9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>n = number of children with symptom; N = total number of children; NS = non-significant.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2016-10-03 23:13:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<COMPARISON ID="CMP-001" MODIFIED="2016-10-03 23:13:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="1">
<NAME>Oral appliance versus no treatment</NAME>
<DICH_OUTCOME CHI2="4.094501552761378E-31" CI_END="0.7619416580509972" CI_START="0.1955122310714755" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3859649122807017" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="100.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.11807828135927273" LOG_CI_START="-0.7088260683412978" LOG_EFFECT_SIZE="-0.41345217485028524" METHOD="MH" MODIFIED="2016-10-03 23:04:04 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="1" P_CHI2="0.0" P_Q="1.0" P_Z="0.00607923764134403" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="99.99999999999999" Z="2.7434766236745065">
<NAME>Apnoea-hypopnoea index measured by polysomnography</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7619416580509975" CI_START="0.19551223107147556" EFFECT_SIZE="0.38596491228070173" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="-0.11807828135927259" LOG_CI_START="-0.7088260683412977" LOG_EFFECT_SIZE="-0.4134521748502852" ORDER="1871" O_E="0.0" SE="0.3470081743219488" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.120414673046252" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.781949141040545" CI_START="0.10927309985156103" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.5777156842356306" LOG_CI_START="-0.961486736713457" LOG_EFFECT_SIZE="-0.1918855262389131" METHOD="MH" MODIFIED="2016-07-25 15:40:24 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.6250682661433411" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="0.48868000136185497">
<NAME>Daytime symptoms: Sleepiness measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.781949141040547" CI_START="0.10927309985156103" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5777156842356308" LOG_CI_START="-0.961486736713457" LOG_EFFECT_SIZE="-0.1918855262389131" ORDER="1872" O_E="0.0" SE="0.9041351212403583" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.8174603174603174" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.407000582153501" CI_START="0.07343019458633078" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.32142857142857145" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.14829427712628857" LOG_CI_START="-1.1341253209320772" LOG_EFFECT_SIZE="-0.49291552190289434" METHOD="MH" MODIFIED="2016-07-25 15:41:02 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.1318932242101286" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="1.5066779575314442">
<NAME>Daytime symptoms: Irritability measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.407000582153501" CI_START="0.07343019458633078" EFFECT_SIZE="0.32142857142857145" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.14829427712628857" LOG_CI_START="-1.1341253209320772" LOG_EFFECT_SIZE="-0.49291552190289434" ORDER="1873" O_E="0.0" SE="0.753299619978875" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.5674603174603174" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.053134563676804" CI_START="0.06278632499605635" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2571428571428571" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.022483866464266852" LOG_CI_START="-1.2021349362861686" LOG_EFFECT_SIZE="-0.5898255349109508" METHOD="MH" MODIFIED="2016-07-25 15:41:46 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.059026683668832805" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="1.8879945383675842">
<NAME>Daytime symptoms: Tiredness measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.053134563676804" CI_START="0.06278632499605635" EFFECT_SIZE="0.2571428571428571" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.022483866464266852" LOG_CI_START="-1.2021349362861686" LOG_EFFECT_SIZE="-0.5898255349109508" ORDER="1874" O_E="0.0" SE="0.7193471466964454" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.5174603174603174" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.781949141040545" CI_START="0.10927309985156103" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.5777156842356306" LOG_CI_START="-0.961486736713457" LOG_EFFECT_SIZE="-0.1918855262389131" METHOD="MH" MODIFIED="2016-07-25 15:42:19 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.6250682661433411" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="0.48868000136185497">
<NAME>Daytime symptoms: School problems measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.781949141040547" CI_START="0.10927309985156103" EFFECT_SIZE="0.6428571428571429" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.5777156842356308" LOG_CI_START="-0.961486736713457" LOG_EFFECT_SIZE="-0.1918855262389131" ORDER="1875" O_E="0.0" SE="0.9041351212403583" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.8174603174603174" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.231442036679705" CI_START="0.12081405845558105" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.38571428571428573" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.09041397464642449" LOG_CI_START="-0.9178825263569634" LOG_EFFECT_SIZE="-0.4137342758552695" METHOD="MH" MODIFIED="2016-07-25 15:42:51 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.10773360834584655" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="1.608463937024737">
<NAME>Daytime symptoms: Morning headache measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.231442036679705" CI_START="0.12081405845558105" EFFECT_SIZE="0.38571428571428573" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.09041397464642449" LOG_CI_START="-0.9178825263569634" LOG_EFFECT_SIZE="-0.4137342758552695" ORDER="1876" O_E="0.0" SE="0.5922783558375663" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.3507936507936508" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2175832017608612" CI_START="0.021213401757924397" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.16071428571428573" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.08549864777662214" LOG_CI_START="-1.6733896829103732" LOG_EFFECT_SIZE="-0.7939455175668755" METHOD="MH" MODIFIED="2016-10-03 23:04:43 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.07682409009967" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="1.7694183228906841">
<NAME>Daytime symptoms: Thirstiness in the morning measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2175832017608612" CI_START="0.021213401757924397" EFFECT_SIZE="0.16071428571428573" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.08549864777662214" LOG_CI_START="-1.6733896829103732" LOG_EFFECT_SIZE="-0.7939455175668755" ORDER="1877" O_E="0.0" SE="1.0331797120831967" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="1.0674603174603174" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.5919078396132387" CI_START="0.0436369987083296" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.16071428571428573" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-0.22774590791085852" LOG_CI_START="-1.3601451272228926" LOG_EFFECT_SIZE="-0.7939455175668755" METHOD="MH" MODIFIED="2016-07-25 15:43:44 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.005989928567484261" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="2.7483322022483705">
<NAME>Daytime symptoms: Oral breathing measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5919078396132388" CI_START="0.0436369987083296" EFFECT_SIZE="0.16071428571428573" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="-0.22774590791085844" LOG_CI_START="-1.3601451272228926" LOG_EFFECT_SIZE="-0.7939455175668755" ORDER="1878" O_E="0.0" SE="0.6651769068904283" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.4424603174603175" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.694318249938515" CI_START="0.04858858795649127" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.1836734693877551" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-0.15844141929849925" LOG_CI_START="-1.3134657218798782" LOG_EFFECT_SIZE="-0.7359535705891888" METHOD="MH" MODIFIED="2016-10-03 23:13:58 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="9" P_CHI2="1.0" P_Q="1.0" P_Z="0.012500779602423311" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="2.497683363760802">
<NAME>Daytime symptoms: Nasal stuffiness measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.694318249938515" CI_START="0.04858858795649127" EFFECT_SIZE="0.1836734693877551" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="-0.15844141929849925" LOG_CI_START="-1.3134657218798782" LOG_EFFECT_SIZE="-0.7359535705891888" ORDER="1879" O_E="0.0" SE="0.6784669927988098" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.4603174603174603" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.5488215929476079" CI_START="0.05608143253530873" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.17543859649122806" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="-0.2605688099953414" LOG_CI_START="-1.2511809013496415" LOG_EFFECT_SIZE="-0.7558748556724915" METHOD="MH" MODIFIED="2016-07-25 15:44:48 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.002780156548396654" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="99.99999999999999" Z="2.991054736495497">
<NAME>Night-time symptoms: Habitual snoring measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5488215929476079" CI_START="0.05608143253530873" EFFECT_SIZE="0.17543859649122806" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="9" LOG_CI_END="-0.2605688099953414" LOG_CI_START="-1.2511809013496415" LOG_EFFECT_SIZE="-0.7558748556724915" ORDER="1880" O_E="0.0" SE="0.5818904460704525" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.33859649122807023" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.8380168187594049" CI_START="0.054794088040996655" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-0.07674726511542282" LOG_CI_START="-1.2612662968017283" LOG_EFFECT_SIZE="-0.6690067809585756" METHOD="MH" MODIFIED="2016-07-25 15:45:17 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.026832655308197655" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="2.2139436531048258">
<NAME>Night-time symptoms: Restless sleep measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.8380168187594049" CI_START="0.054794088040996655" EFFECT_SIZE="0.21428571428571427" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="6" LOG_CI_END="-0.07674726511542282" LOG_CI_START="-1.2612662968017283" LOG_EFFECT_SIZE="-0.6690067809585756" ORDER="1881" O_E="0.0" SE="0.6957923426763075" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="0.48412698412698413" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="4.927825248901957" CI_START="0.01002119871446059" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="0.6926552984292502" LOG_CI_START="-1.9990803259799375" LOG_EFFECT_SIZE="-0.6532125137753437" METHOD="MH" MODIFIED="2016-07-25 15:45:46 +0100" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.34147136803056677" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="9" WEIGHT="100.0" Z="0.9512620701979647">
<NAME>Night-time symptoms: Nightmares measured by questionnaire</NAME>
<GROUP_LABEL_1>Oral appliance</GROUP_LABEL_1>
<GROUP_LABEL_2>No treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours oral appliance</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no treatment</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.927825248901957" CI_START="0.01002119871446059" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6926552984292502" LOG_CI_START="-1.9990803259799375" LOG_EFFECT_SIZE="-0.6532125137753437" ORDER="1882" O_E="0.0" SE="1.5811388300841895" STUDY_ID="STD-Villa-2002" TOTAL_1="14" TOTAL_2="9" VAR="2.4999999999999996" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2016-07-26 23:32:01 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2016-07-26 15:35:39 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram, 2016 search.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUIAAAK8CAYAAACa3bZoAAA7ZklEQVR42u2dD4RVzf/HI0mSRPJY
SSJJshJJkmRZSfKVJXnk8fUVyUqSeCQrSSRZSSJZj+QRSZKsJStJHpG1kseKJFlJZCVJ5uc9P3PN
nc6ZmXPv3dq99/Xi2L33/J1zZl535sw5n5ljZhFz5sxh6qAJ4Ke5ZTZJEDosc3LNARFSIIBrD4iQ
ggDkAUCEFAIgDwAipBAAeQAQIYUAyAOACCkEQB4AREghAPIAIEIKAZmUPACIMH6IX758MatXr648
v+hNhrlz59Ytc+LECbNo0SKzYMEC09fXZyYnJ5EIaQBEOLMKwbdv38zevXtLl0nN97l79645efJk
7fP58+fNpUuXzPfv3+105swZs337diRCGgARzqxCIDG9efOmdJnUfIdE193dbaampmrfrVq1ynz+
/LluuXnz5kWP8+nTp2bZsmVm48aNte9Pnz5tFi9ebBYuXGiOHj1at87Xr1/NgQMHbI1zzZo15smT
Jz/USLWe5istb9++je5P6Th8+LCtxXZ1dZmbN2/Wpf3+/fs2Dar5rl+/3oyOjiJCgNkuwpGRkegy
qfmOK1eu1NUGQz59+mSFtn///uhx9vf3Wxm9e/eutt3r16/b71Q7lZjOnTtXW+fUqVPm1q1b9v97
9+6ZtWvX1uZduHChrkaqbUmasf1dvHjRnD171n73/v17s3Xr1rq0S4IPHjyw/w8PD1vZI0KANuks
SS2Tmq/a4OvXrwvn7du3z9bKND1//jy6D7/GJjZs2GCl5OPLR+IL5zvWrVtna4x+7XHp0qXR/alm
6K/z7NmzurSr9ujES9MYABHWePnypdm0aVNyH2qmqjlZZR+qgcU6ZGJN7bDjJly+bH9hk99fTrVA
fZagBwYGECEAIvx/BgcHreRSqGmbukeYI7OYuFLz/H3kiLBoOd1XVDO8t7fXHD9+HBECIEJje5Ul
hhA1I3WfraxpmrMP1SB1f7EMPdZT1jTWumHTeP78+dH9bd68uW6dFy9elKZ9bGxs1ggGEQIinGYR
6p6d62wIm8JqPrrOij///NNOVfahDg/XeaFJn/1HcNRZouaqePjw4Q+dJaqtunUvX75c9zxk0f5u
3LhhH/NxnSU7duyoW07bV8+xUKdJrEaKCAERdpAIJYOiWpmawuqVVS1MHSWp5nPZPtQbrcdZtJ3d
u3fXSVcPe+tBbR2DOkfUuRHK2HXUqMd4YmIiuT89/6iaqx7ZUU+zv5yaxdqPmuzap5MiIgRESCEA
8gAgQgoBkAcAEVIIgDwAiJBCAOQBQIQUAiAPACKkEAB5ABAhhQDIA4AIKQRAHgBESCEoZXx8fEac
i5lyHIgQEOEMKQTNht6qgv+Ob7htF+xUEV1asd/Y+rHjaGdpIUJAhA0WglYWntQrei7Y6XTvK5yH
CAGoEdb+T4WoF7GQ+VpWkaRXrFhRew/XyS2MJ+jvOzYvZ785x+0fY9G+FJih6Ljd/KLhA1JDAKSu
gdKkY16yZImNoh2GB4sdEyIERDhNIkyFqE+FzNeyCojghBBGZonVxGLzUvtNHXdOjXDXrl3R4w7D
+ecMARDbr9KjOIbumLds2fLD+YgdEyIERDhNIkyFqE+FzC8Ke58ru9i81H5Tx50jwtRxh/NzhgCI
7VcxD/1hTcNjTh0TIgREOE0iTIWoT4XMTxX+RkVYNVR/eNw5Iqxy3KKRIQD878IOm/CYc5rWiBAQ
4U8QYTg/FTJ/ukTYSKj+6RZhI0MAVPnRQYSACH+RCFMh6lMh86dLhKn9Vgmt3yoRVh0CQKP7+d9p
oCt/CAON7IcIARHOABGmQtSnQuanCq96V3XfywkkV4Sp/aaOOyR2HLkiTA0B4PfyvnnzxnYixTpL
lB5ECIhwBohQxELUi1jI/FThVU+v1nM1p1wRpvabc9w+sePIFaGIDQHgennVrJcg9cB4uB3JW8er
R350zKlBpRAhIMJpEiHMDDTuyvLly8kDgAgpBJ2Daq8a/tQ9G6na5XSPj0weAERIIZhRjIyM2Ocf
1RzWmyXHjh2zQiQPACKkEAB5ABAhhQDIA4AIKQRAHgBESCEA8gAgQgoBkAcAEc6uQtCpYe8RIUCb
i7DKsmEUFQojIgRE2HEirFq4KIyIEBDhjCsEqTD3r169su/2KlCB3p1ds2aNuXPnTm2bYdj72PJu
HQU80Lu5Wmbnzp02KGnO/oQb5Env8CoCzOjoaF16YiH9ESEiBERY+H0qzH13d7eN7uKirCg8vcbu
KNtuzvIuOrPm37592/zxxx/Z6/tRXYaHh+siVadC+iNCRAiIsPD7qmHuRSoqdWp5vwYoabkhPHPW
lxRv3bpVuFwqpD8iRISACAu/zwlzrxHcTp06Zfbv32/H6kiFqKq6fHgMsfVVC9RnSW9gYOCH7cRC
+iNCRAiIMEuE4bJDQ0Nm7dq15tq1azZQgOIAxsRWdXnh9zyn1neiVOSW3t7euogtSA8RAiJsqBCk
wtyrE8UPkx+GnA+3m7P8y5cva5+1bz8OX2p9n7GxsUoh/REhIgREWPh9Ksy9Bhh3vbaSpMbaiIXf
Ty2v/3t6esyHDx/sPtVR43eWpNZXbVE9xyIc6zcV0h8RIkJAhKXzYmHuHz16ZDscJBxJSB0VsfD7
qeX1v/ahfWkdSdEfvze1vprFum+oZrCWcVJ0pEL6I0IARAiIEAARAiIEQISACAEQISBCAEQIiBAA
EQIiBECEgAgBECEgQgBECIgQABHOxmOkICNCQIQdL0Lg/AIinJZC0Ezo+5yw/Ho3WMFUFQBWKDiD
C9Ov5Z88eVK3/ODgoA284N4ldtGowzTof0WjLlvWHbveO16yZImNdN3pIkCEgAgj8QgbDX2fE5a/
v7/fznPBDxRw1UWYVkxBBVbwl9+1a1ctCEMYXSYUoSRctqyOW7EKXVSdLVu2IEJECIiw+BBbHfo+
DMvvR5YREl+4zdjyZbEPU8u6cVEcOUMQIEKADhVhs6Hvmw3LnzrGmAhjy4bjLRcNQYAIARBhncwa
CX3fSFj+nyXCnLFYECEAIvyBqqHvq4bxF6tXr442jVslQkW21r1Bx/PnzxEhIgREWHyIzYS+zwnL
H6JmtJrj4uHDhz90lrRKhGFniY4bESJCQISlzeJGQ9/nhOUP+fLli+nr67PraL/+GMetFKHQWCx6
9Kerq8v2gIf3DREhACLsKCRgf7Q8RAiACNseDUalDiD3DOSJEyfqOoIQIQAibHvUi623WdQc1psl
x44ds0JEhACIEBAhACIERAiACAERAiBCQIQAiBAQIQAiBEQIgAgBEQIgQkCEAIgQECEAIgRECIAI
ARECIEJAhACIEBAhQGeJkIKABAEQIQUCCQIgwvqCwdQ5EwAiBGpGAIgQECEAIgRECIAIARECIEJA
hACIEBAhACIERAiACAERAiBCQIQAiBAQIQAi5CIhQgBEiAi5TACIEBFyEgAQISIEAESICAEAESJC
AECEiBAAECEiBABEiAgBABEiQgBAhIgQABAhIgQARIgIAQARIkIAQISIEAAQISIEAESICAEAESJC
AECEiBAAECEiBABEiAgBABEiQgBAhB0iwHACAESICAEAEXayDAEAESJCAECEiBAAECEiBABE2Lky
BABEiAgB4OeIsOhxDSYmpjk8ytQpIuTCAlBT72gRckEBkGGHX0cuJAAyRIScBQBEiAgBABEiQgBA
hIgQABAhIgQARIgI4dcyPj7OSZil54Ey1OYivHnzplm5cqWZP3++2bRpkxkbG6vNm5ycNP/5z3/s
vAULFpi+vj7z/v377PU7PZPfv3/fzJs3z2zYsMF+1jmabenxt9Wq7f6s84AIIUuE//zzj9m8ebN5
/fq1+f79u7lx44ZZu3Ztbf6OHTvM33//bedp0v89PT3Z63d6JpcEHzx48NML03SJsJOlggjbWIT7
9+8358+fjxbk2Hep9Ysy09OnT82yZcvMxo0ba9+fPn3aLF682CxcuNAcPXq0bp2vX7+aAwcO2Brp
mjVrzJMnT+rmnzhxwq6n+du3bzdv376N7k/CPnz4sFm0aJHp6uqyNVr//Lha3Ny5c8369evN6Oho
aXpevXpldu/ebfetdXR8d+7cqe075x3WWNrLzpdPKj1F1z6cPzQ0ZJYuXWqPob+/33z58iVZI4xd
lyrnJec8VLkmiBAqi3DFihXR+zWuRui4deuW2bZtW/b6RZlJBU2F9927d/a7K1eumOvXr9vvvn37
ZgvyuXPnauucOnXK7lfcu3evrsZ54cIFc+nSpVqNVdtS4Yzt7+LFi+bs2bP2OzXzt27dWpfJ/Vrc
8PCwWbVqVWl6uru7bS3Y7V/HImmVFZ7wcyrtRccfkkpPjgjVdNcPiLYhIR05ciQpwth1qXpeUueh
yjVBhFBZhMpgylj6xXb3AD9+/Fib//LlS7NkyZLar7f+13e56xdlJr/GJlQIVQB8/IyuAhbOd6xb
t87WTPxaimo2sf2pZuWv8+zZs7pMrgLrCngjqNaSK8JU2ouOPySVnhwR+rW5z58/m+XLlydFGLsu
Vc9L6jw0e00QIURFqO8PHTpkPn36VKtRqbnrUPNGtS73y65m8N69e7PXz8lMkmnYXPILTVHzvKhw
FS1ftr+waekvJ7G7WtLAwEDy5KrpqtqR0i0xxyQUfk6lPafwpdKTI8JQQmXnMKw5t+q8pM5D1WuC
CKGSCHVfya9NqED4PXr63y8k+l81v9z1czJTkcxS9ylj81ISSK3jCrGae729veb48eOl+9e9NdWM
rl27ZkZGRmzztYoIU2lvRIQ556DKOWpEhFXPS+o8VLkmiBAqi3Dnzp0/1CZ80fn/u/m6mZ27fk5m
0s1v1SjLWL16dWkTTOuGTWNfxEX7Uy+3v86LFy9KM7keBYoVAP0Q+Meu3vMqIkylPafwpdITbqPo
GP1HnnRrQ+lKiTB2Xaqel9R5qHJNECFUFqHuu2hyTd/BwUH7LKBDN+r1q64b2JqvG/PqocxdPycz
qentbvZr0mf1/jrUvFLTSDx8+PCHzhLt0617+fJlW0Bj+9NN/DNnztQ6F9QhFN77Ui+l0A36WM1H
nUWuN1QCUtpjBV4/Errn58SVSntO4Uulx+9oePPmjb3dER6j9ql1tY0///zzh9sfRf/HrkvqvFQ9
D1WuCSKEyiIUEoluRqsmpULy77//1ubpMQrJUPM0SYL+oxWp9XMz08mTJ20twm3D7yHV/tQJo8yv
e03qDPBxj89oUo/xxMREcn+616lOFT2uofua/nJqgmk/aq5pn64AFvHo0SN7U1/LqbDqRyEmQvWE
unOZk/bcwhdLjxOH0qMfCaUnPEZJ67fffrPX8dixY3UdXmXpiV2X1Hmpeh6qXBNECA2JEDo+c3AS
OE+IECjgwHlChNDRzMb3fhEhIEIARAiIEAARAiIEQISACAEQISBCAEQIiBAAEQIiJLMCeQsQIZkV
yFvQEhE2Ejpf6ygQg95tVaBWRbDWS/J6TzQco0MUhdKfmpqywT/D95b1Er4ikeQcRypEPQAihGwR
Vg2dr3X++OMPO+/u3btWRAcPHrSfw8ggsVD6Cuiq+T6KbiP55RxHKkQ9ACKEbBFWDZ0frqPPfiw5
f1+xUPoK+a9aoduX/mpYULft1HGkQtQDIELIFmFI1fDxsc+pUPoaCEq1PqG4egq/lHscqRD1AIgQ
GhZh1fDxsc+pMPIKva6Bn4TuDSqse+5x5ITcB0CE0JAIq4aPj31OhdIXimas+31qFlc5jioh9wEQ
IVQSYdXw8bHPqVD6Qh0g6vX1O0JyjiMVoh4AEULDIhRVwsenPsdC6YsPHz7Y/UhmVY5DxELUAyBC
yBIhACBCRAgAiBARAgAiRIQAgAgRIQAgQkQIAIgQEQIAIkSEAIAIESEAIEJECACIEBECACJEhACA
CBEhACBCRAgAiBARAgAiRIQAgAjb9xpyIQGQICLkggIgQURYf2GZmJjyJmhTEfLLDgCIEBECACJE
hACACBEhACBCRAgAiBARAgAiRIQAgAgRIQAgQkQIAIgQEQIAIkSEAIAIESEAIEJECACIEBECACJE
hACACBEhACBCRAgAiBARAgAiRIQAgAgRIQAgQkQIAIgQEQIAIkSEAIAIESEAIEJECACIEBECACJE
hACACBEhACBCRAgAiBARAgAiRIQAgAgRIQAgwnYUYDgBACJEhACACDtZhgCACBEhACBCRAgAiBAR
AgAi7FwZAgAiRIQAgAjDZiJT+09AviffByKkYFAT5hxAp17zOWQGMgVph06/9nPIDNCJeYB8D34e
QISACAERkiEAEQIiJEOQIRAhIEIyBBkCEQIi5IyQIUgzIEIgQ5BmQIQl3Lx506xcudLMnz/fbNq0
yYyNjdXmTU5Omv/85z923oIFC0xfX595//599voUGNI4U9Mcy7dFbyrMnTu3Nn9qasocOHDArrt0
6VJz9OhR8/HjR/LEbBXhP//8YzZv3mxev35tvn//bm7cuGHWrl1bm79jxw7z999/23ma9H9PT0/2
+mQI0jgT01w13969e9ecPHmy9vngwYPm3LlztXIxODho9u7dS56YrSLcv3+/OX/+fOlG5s2bF/0u
tX7RQT19+tQsW7bMbNy4sfb96dOnzeLFi83ChQvtr6vP169f7a+vaqRr1qwxT548qZt/4sQJu57m
b9++3bx9+za6P2Xcw4cPm0WLFpmuri5bM/DPz/37920aVQNYv369GR0dRYRtluYq+Vb5pbu729YC
HaoJ6nt/GeUn8v0sFeGKFSvM+Ph46UZcjdBx69Yts23btuz1iw6qv7/fXpR3797Z765cuWKuX79u
v/v27Zu9QPq1dZw6dcruV9y7d6/ul/vChQvm0qVLtV9mbUuZJ7a/ixcvmrNnz9rv1MzfunVr3clS
Znjw4IH9f3h42KxatQoRtlmaq+Rb5Sm/NlgkQklL35HvZ6kIlXglWr847h6gf6/j5cuXZsmSJbX7
JPpf3+WuX3RQ/i+X2LBhQ12mEv5FUAYI5zvWrVtnM6GfIXXPJrY//UL66zx79qzuZOlX1GVAmsbt
meYq+Va1QTWhfSQdNYeVL798+WKOHDlSdw+RfD/LRKjvDx06ZD59+lT7ZVGzwbF792776+N+edSc
8O+FpNbPyZjKlLEb00XNc0dR5vOXL9tf2PTxl1MB0Wdl1IGBAUTYhmnOzbf60VdHSoikuW/fPpuX
Vq9ebfNMqkZIvp/BItT9Av9XQifHv6BF90L0C5q7fk6GiP2SpjJE0bwg4ZXXEbq/ouZIb2+vOX78
OCJsszTn5lvV+nQvLsWLFy/sfTfy/SwV4c6dO3/4lfBF5//v5usGbe76ORlCN2b1y1yGfnHLmgha
N2wi+Bm6aH/qLfTXUSYuOz96pKJdBIIITeV8q9aPxJDi9u3blVtC5PsZJELdE9DkPwbgNwV0w/Xa
tWv2Zq7m64arep5y18/JEGp6u5u4mvRZvWAO3TRWtV08fPjwh5vG7l6NpsuXL9sMFNufHpU4c+ZM
7aaxOoT85bR99aAJ3TyO/TIjwtmZ5tx8q3t2rrPBR3lE8hOvXr2yNSjdcyPfz1IRuuq/bpTqF0X3
BP/999/aPN0Ilgw1T5MkqO9y18/NmOqVU3PFbcPPfNqfbmbrwugmcZjh3GMEmnQTe2JiIrk/3evU
zWU9uqD7Q/5yah5oP2q6aJ8ucyDC9kpzTr7V9S+qlSkPqvPB3SNMdTKQ72eBCAEpkGbohDyACAER
AiIkQwAiBERIhiBDIEJAhGQIMgQiBETIGSFDkGZAhECGIM2ACIEM0YZpiqWLfA+IEDpGhOGECAER
UiOInosyebTr1GCBaZs83OllABGSCagRNijCdrpuiDBDhLHw3LFQ4Y2EHk/N1zYVsVfRg937ji5i
bs76qVDkiJB7hLl5JTeEfayMKBiD3h/WPK2v+Xfu3ImWoZw8TBmYBhHGwnPHQoU3Eno8NV/bVMZx
kXXDCBip9VOhyBEhvca5eSU3hH2sjCiytSK+uAgxCq0v6cXKUOq4KAPTJMJYeO5YqPBGQo+n5hdt
0z/u1PqpUOSIEBHm5pXcEPaxMlKEH4y1kXD6lIFpEmEsPHcsHlmjocdj84u2Gf4yVwltHoYiR4SI
MDev5IawT8XsU9NXtUYFbVWIq6pRpMPjogxMkwjdxSoKz11VhKnQ46n5KRE2EtocESLCRvJKbgj7
WBkZGhqyNUYFNh4ZGbHN32bD6VMGplGEjjA8dyxUeCOhx1PzUyJMrV8lFDki7Ow0p/JKbgj7WBlR
h4WfXzUSXmofqeOiDEyTCGPhuWOhwhsJPZ6anxJhav1UKHJEiAhz80puCPtYGdHTD66XWELSUAAp
EaaOizIwTSKMheeOhQpvJPR4an5KhDnbj4UiR4SIMDev5Iawj5WRR48e2Y4MzZMg1eGSU+tM5WHK
wDQ3jQERkmZAhIAUSDMgQkAKpBkQISAF0gyIEJACaQZECEiBNAMiBKRAmgERAlIgzYAIASmQZkCE
gBRIMyBCQAqkGRAhIAXSDIgQkAJpBkQISIE0AyIEpECaARECUiDN0F4iJFOQGUg7dPq1n0OmIDNw
DqDTr/mccAGmzpmAfE++LxAhvxAA0JEO4BQgQgBECIgQABECIgRAhJwERAiACBEhpwEAESJCTgIA
IkSEAIAIESEAIEJECACIEBECACJEhACACBEhACBCRAgAiBARAgAiRIQAgAgRIQAgQkQIAIgQEQIA
IkSEAIAIESEAIEJECACIEBECACJEhACACBEhACBCRAgAiBARAgAiRIQAgAgRIQAgQkQIAIgQEQIA
IkSEAIAIESEAIEJECACIEBECACJEhACACBEhACBCRAgAiBARAgAiRIQAgAgRIbT19WfqnAkRIkLg
2nPNC645uYDCwHWHjr/25AQKBNccOj4PkBsoFFxzQIScDgoF1xwQIVAouOaACIFCwTUHRMgJoVBw
zQERckI4DVzz1jM+Ps6JRoQUCpid1/zEiRNm0aJFZsGCBaavr89MTk42tI/58+e3trBOYz4dHh42
u3btqn3+9OlT9lsZiLANTkQ7X2ioLsLz58+bS5cume/fv9vpzJkzZvv27b/sB/Zn5ckNGzaYly9f
1j7fu3fP/ghQI0SE0IEiXLVqlfn8+XPdd/PmzSvdzv379+38uXPnmvXr15vR0dHCvFW2T/87iffw
4cO2NtrV1WVu3rwZrRGePn3aLF682CxcuNAcPXo067iKePz4senp6an7Tj8Ag4ODiLATZQiI0EfN
Q8lm//79pctINg8ePKg1LyXSsn2kRHjx4kVz9uxZK8T379+brVu3lorwypUr5vr163bZb9++WWme
O3cu67hCjhw5YoaGhuq+27t3r5WjRCsx63YBIkSE0GEi3Ldvn61paXr+/HnpcsuWLTO3bt3K2kdK
hBs3bjRfv36tfX727FmpCNWUlQTD2mzOcYVs2rTJvHjxou673377zfz111+1murVq1fNqVOnECEi
hE6rEQrVhNS0LEO1LW1LYhoYGGhKhGETXAIqE6GWDZvfagbnHFeIOoVCqYZovuSICBEhdKAI1eyM
3SMUT58+tZ0Lvb295vjx4y0T4Q+F1fvfl17V4wrJ2VaV5RBhmxcKaP9rrial7s851FRdunRp1jbH
xsainRvh59evX9d9t3nz5rqmsZqrZdtTLVX3MBs5rpwaodI8NTVVdx7WrFmDCBEhdMI1V1NYTUn3
+Myff/5ppzLWrl1re2iFOif8Wp0E8/bt25rc/A6MN2/emN27d9cdx40bN2xvress2bFjR6kIL1y4
UOtY0aTP/mM+seMK0T1C3Y/0OXbsmO0octtXR8zly5c7Q4SE8SZkeaeLUE3h/v5++zC0OkpSvaVq
fq5bt842GyUbJx8heWg77sFqJyQtu3r1artseBx6jlG1MfXWqmc4VsM8efKk7dHV9iXVd+/eZR1X
iHqNtS+fL1++mIMHD9ptL1myxEq3nfPAHGpFyIC0dzZPnjxp+KHxthIhmQIZku7ORr3LnfZudFDb
JkMgwzmkucNRs33Pnj2IEBAhaQZECGQI0gyIEMgQpBkQIZAhSDMgQiBDkGZAhDOUVnXrT8fjAe3w
yAEiBERYkiGK3kSIvXTtAkHqeaQGDiK6bCtCnrdyO7Ft5hawmVQQEWH7HK/eMHn48CGWm64a4d27
d+0rPWX471G2WoStyrTTkfkb3SYiJM3TcbwKt6+4hjANItRL193d3XXRKGK1x7ILVya/2DGUvR9b
FqZcATX9X0TVVHfu3Jn1nu2rV6/sL6pelpfYFW3jzp07dceidzgVoUSZLZVuvWx/4MABuz1tS68y
laW5VWHXEWFzaQ6vcc71iV1nofeVtZ7m61U2BWKI7S8Vsj+VHxRZWuH3ocUi1AvZsdpgUcZqlQiL
5sfClOvFc0XT0Dy9OK6ovW5QmtR+JHtFAHERNzSIjzKofxx6IV/z3AvusXQroq+LEqy4cIoIUrRc
K8OuI8LmRRhe49T1iV1nRYXxB4PStiTN2P5SIftT+eHatWs2kAK0WIQShGKnzRQRpsKUK7MpMymz
+hmikQLv3xfV+v6veSrdKhBlkX+nK+w6ImxehOE1Tl2f2HVWBBg/xmAY37Bof6mQ/an8oDiGqgxA
C0Wo2lTOSf2ZIkyFKXeZVxnuw4cPlQq8min6hdeAPcrEqeOMpTsWA266wq4jwuZFGJK6PrHrXNTB
6C9ftr/w1pS/XCo/aHk1xaGFItSQfjkjWLVChGX38cJt5YQM12DV+qWuIkKN5KV11LQYGRmxTZWf
IcJWhl1HhK0XYer6xK5zlfD7uevk5IfU8AJQUYQa1k8nvFkRhmHJm6kRpsKUK5Ku7umE90pS+9HN
aX+7sWPOSbeCb+Y0jVsZdh0Rtl6EqesTu85aN2wa+49cFe0vFbI/lR90H5MaYYtFqHshfuTbKs3X
WFjyKiIMQ57HwpTrWLds2VKXEf/999/C7YSsWLGi1kvs7rOkjjPcZthZomaMUE92WWdJK8OuI8LW
izB1fWLXWcuqVeXW1Y+0xBnbXypkfyo/aPhR7hG2WIQ6yamh/oouaCoseRURhiHPRVmY8r6+vrrH
Z/S/5pdtx+fRo0dW/DpuZTbdkE4dZ7hNfxn1Wut4tD3db/THhZiusOuIsPUiTF2f2HUW7vEZTeox
npiYSO4vFrI/lR80BjG9xi0WIXSuFEjz7ESP20iWgAgBKXRkmnVLJ/c1V/I9IgRE2JbpUrh93jVG
hIAUSDMgQkAKpBkQISAF0gyIEJACaQZECEiBNAMiBKRAmn8Os3moCkSYURiqDj2AFEjzdO3rV68f
216jQ1UgwllSGKoOPYAUSHOniDC27bYTYSpsfSxceCqUeKNh6ZvZbir8eXiCisKBVQ25jhRmZ5qr
DgMhcodlSEUwysmnrcrnIStXrqyFrXORl/755x/7eXJy0s73j7dsqAoFmVAAE/cu9EytUGSJMBW2
PhYuPDavmbD0zWw3Ff48VVAaCbmOCGdfmhsdBiJ3WIaUCFP5tNX53Of33383t2/ftv///fffttmr
/bnPLr/H0qPPigXqKgnTES3plzeN/QCVsXDhsXnNhKVvZrup8OepgtJIyHVEOPvS3OgwELnDMqRE
mMqnrc7nPgpMfOjQIfv///73PxulXZP4448/rHRzRJgazmLWiTAWtj4WLjw2r5mw9M1sNxX+PFVQ
Ggm5jghnX5obHQYiNxp5SoSpfNrqfO6j2q1agkK3nhT0dfny5fazmvtu3KKUCGdL/soSYSpsvRNl
WbjwsnnNhqVvdLs54c9j8xoJuY4IZ1+aGx0GYrpEGM5vdT4PWbJkiW1SOwHqXp8i2rjPHSfCVNh6
n1j4+HBeq8LSV91ulfDnRRevkZDriPDXpqnK9c3NR2XDQOQOy5AawiKVT1udz0M0NMd///vfWpPY
NY/d544TYSpsfSxceGxeM2Hpm9luKvx56uI1EnIdEf56EeYOCJaTj2LDQOQOy5AawiKVT1udz0OU
x9XsV/4WinatnnDJvyg9saEq2kKEqbD1sXDhqVDijYalb2a7Ihb+POfiNRJyfTaJsEwe7TqV0cgw
ELnDMqSGsMjJp83m81jaHz9+XPfYjOtsccIP148NVdEWIgTul3VijbATUI8wIELgHmFHi1DNeECE
gBQIugCIEJAC+R4QISBC8j35HhECIiTfk+8RISBCLjz5HhECIgTyfduIcDaHCkcKpBlmuQgbfTi1
ynply8ZChQNSIM3wS0T4MzJjLJo0IAXSDNMmwlhI8FjNTuvpXUiF9FFU51jNTi9suxDnCnte9o5m
0f/h61MulpqPovgqhNDU1BRXHilk/bAWDbkQKwvNDGshUkNAKOBBWej71LahSRGmQoKXSUrrKE6g
i36haB0xoSlskMZD0PIKE65IuFWaxv7/irQRZgQdz8GDB7nqiDBbhOGQC6my0MywFjlDQEiyZaHv
Y9uGFogwFRK8TEZObI4wVHj4v18D1P784TOritAFbPXRr/rz58+56ogwW4RhqPlUWSgid1iLRoaA
8I89tm1ogQhTIcFzOy/CUOGpzpKy8Pe521ATwg2oI8nOthHlEOGvF2HVsiAaHdaikSEgcrcNLRBh
KiR4mYxSYyakRFgW9Tl3GwpK6QagURNDgSUBETYjwlRZaGZYi0aGgKgyZAY0KcJUSPCyi6VI1ro3
6FCzNCYxV3tzzYKcsRFiGUX71k1nNc91c1sBMwERNiPCVFloZliLRoaAaGTIDGhQhKmQ4LmdJVon
JrGenh47CI6W1/6qdpaEocJdTXDPnj32pjcgwmZFmCoLzQxr0cgQELnbhhaIUMRCgqeap6qNdXV1
2V6wWHNX87WslpEUw0cHUv+HocLFkydP7DK8dYIIWyHCVFloZlgLUXUIiCrbhhaIsBWoaeo3d38G
yqT6lQZESJrhl4hQXf+6ceueudKv3c+8gav96tebHjSkQJrhl4lQvWZ6ZEVNCL1ZcuzYMSvEn4Xu
GaqJTScJUiDNMGOaxoAUSDMgQkAKpBkQISAF0gyIEJACaQZECEiBNAMiBKRAmgERAlIgzYAIASmQ
ZkCEgBRIMyBCQAqkGRAhIAXSDIgQkAJpBkQISIE0w4wUIZmCzEDaodOv/RwyBZmBcwCdfs3nhAsw
dc4E5HvyfYEI+YUAgI50AKcAEQIgQkCEAIgQECEAIuQkIEIARIgIOQ0AiBARchIAECEiBABEiAgB
ABEiQgBAhIgQABAhIgQARIgIAQARIkIAQISIEAAQISIEAESICAEAESJCAECEiBAAECEiBABEiAgB
ABEiQgBAhIgQABAhIgQARIgIAQARIkIAQISIEAAQISIEAESICAEAESJCAECEiBAAECEiBABE2PYC
DCcAQISIEAAQYSfLEAAQISIEAESICAEAESJCAECEnStDAECEiBAAEGHYTGRq/wkAAhFSMKgJA3S0
CCkQyBCgw8sBBYFMQB4ARMhZIBNwEgARAiIEQISACAEQISBCAEQIiBAAEU4n4+PjnGlECDB7Rfjl
yxezevXqpnYyf/78X1pYh4eHza5du2qfP3/+bA4dOmQWLlxoj62vr898/PgREQIgwh/59u2b2bt3
b9MFpRUFrZltbNiwwbx8+bL2+ciRI+by5cvm+/fvdjpx4oSVISIEQIQ/sH37dvPmzZusgnL//n0z
b948M3fuXLN+/XozOjpaK2Th+61F2/O/k5wOHz5sFi1aZLq6uszNmzft/ImJCdPd3V0o7OXLl5up
qakf5j1+/Nj09PTUfbdkyRK7D3/9VtRaESFAG4pwZGQku6BIgg8ePKg1RVetWlVa0FIivHjxojl7
9qyV1fv3783WrVtr83fs2FGTrOP69evm4MGDhcel2t/Q0FD02L9+/WqWLVuGCAEQYXMFRSK5detW
1vopEW7cuNHKyfHs2bPa/Hv37pne3t66dbX88+fPC/e9adMm8+LFi+ix//XXX+bUqVOIEAARNldQ
VAvUcrofNzAw0JQIVbv0Uc3Qn79ixYraPT9JUiIsY8GCBXXN4JAPHz6Yffv22eYxIgRAhE0XlKdP
n9ZqbMePH2+ZCMP5Z86csb2+4sCBA+bq1aulx6R7lmVIfr///rttfnd4JqAkACJsdUEZGxurWycl
wtevX9d9t3nz5rqmsZq2/nyJSzW9yclJs3jxYvuIT9UaoWqCkqn2TSZAhIAIW1JQ1q5da3uOhTpN
/FqdZPT27dua3PyOFfVK7969u24fN27csLU+11miDpLwGFQT3LNnj+nv748el+4Rqvnso57kbdu2
WZECIgRomQjVLF63bp1tikp0Tori3Llz9vEU94iKE6WW1cPaWjbcx/nz583SpUttje/KlSs/zH/y
5In9LvXWinqNtb6PHrUhdD0iBKgkwpnIu3fvbKdJCglTz0MCIgRoKxGqyXzy5MkfeqfLUE827zsj
QoC2EqHuOeptkVgniY+a4rqfCIgQoK2axoAIARAhIEIARAiIEAARAiIEQISACAEQISBCgE4UYe7x
6rW9hw8f/hQB/OoI3jMhgjgAIpyBIlSYrlh4rplUo0KEADNUhPpe7w8r4KovlNOnT9v3fzXw0dGj
R+vWUVAFBUPQA89r1qyxr7f5aGwQraf5eu1NgRhi+ysL2e8oGx7AoYeuFWAhRwD6X5Gu9dqee1/a
BYZIpS0WaSf8LpWm1DnOWR8RArRQhIrsooKn93qFghdIFvpOsfxUCBVQwaEozy5KteISKiKN48KF
C+bSpUu1AZO0LYkltr9YyH4RGx5AXLt2zQZdyBWhmtNOzmEEnVjaqogwlabUOU6tjwgBWixCv8Ym
9M5uGNvPl4/kUBYNWpFp/BiD+l/RZWL7i4XsF7HhAYTiGCoMV64Iw/3782NpqyLCVJpS5zi1PiIE
aLEIQ1RDCkNX+RGgiyJLO4oiRfvLl+0vbBb6y8WGB3DLq3mZK8LY/FjamtlOmKaq5zhcHxECTLMI
Y2HvU7JIhd/PEWHRcmXDA0y3wFq5HX9+I+cYEQL8RBGqQ+LTp0+lG1OQ1bLmo9YNm8b+WMJF+0uF
7PcJhwcQusfWqhphLG2x7VQdhiB1jqucE0QIMA0iVIeHu1GvSZ/9oKfqUFBzVegZvrCzZHBwsLbu
5cuXrVxi+0uF7I8NDyA0xGeVe4Sx+bG0lXXgNDIMQeoc5wxjgAgBplGEQgFR9eiGanMq5K6HVyg+
YF9fn5WBOkfCsULc4zOa1GM8MTGR3F8sZH9seACh0e2q9BrH5sfS5i/XimEIYuc4Z31ECNAiEbYD
erREsgRECNCRItS9M/UmAyIE6FgRKjR/6l1jQIQAbd80BkQIgAgBEQIgQkCEAIgQECEAIgRECNBR
IhwfH5/W5REhQIeJcCYXjrI3Qvx3l3MIl+9UISBCQISzsBC0St4IgPMAkF0jTIWxL0LvFet9WQVP
HRoaqvRe76tXr+w7tgqLr30pNP6dO3eiNcIwhl9qO0XL6+/U1JRZvny5fbfYRxFfFBnGEQunjwgB
2lSEsTD2IQon7yKkKGCAoipXEWF3d7eNsuIisCjEv4SaahqH262yHf/zoUOHbNSXME2Sn0iF00eE
AG0qwlgY+xC94+vXqDTQURURFuEHLM0VYZXt+J81Ap5qhS7+oP6uXLmydg5S4fQRIUCbirBK4UmF
k8/ZnqLGKAbg/v37bdirHPkVbTd3O+Hnbdu22VqfUK1SNWI/fbFw+ogQABE2FJbf/073FBX4VKPQ
jYyM2OZ1IyKssp3ws8L/656i0L1BrV9Uq2yTTEBJAETYahFu2bLFfPz4sfY5DCefCmevThY/XH04
P1eEVbZT9FmdQ7o3qGaxTyqcPiIEQITm9u3btte4LJx8Kpy9BOR6d92QnDnyU++w7uO5MT1S2wmX
D9OkDhANoh52hKTC6SNCAERoUc+qemh/++03K6Mq4ewfPXpkOx+0jJq2Grs4R4QSlh6Sdg9Kp7YT
Lh+m6cOHD3aeZB6SCqePCAHaQIQUto7KBJwEQIQUNkQIgAh/AlXfAwZECNB2IgRECIAIARECIEJA
hACIEBAhACIERAiACA3h8REhACL8qeHxKeCcJ4AZKcJUoANAhAAzRoR6/9e9D6xoK6Ojo2ZiYsJG
fQ5RlGYFMlWY+1hY/7Lw+IODg9FhAGJh8YuOs6iAx5YjEyBCQISFM3whDQ8P1yIwK5JMKBGJ7+DB
g7VCFQvrX1Qj3LVrV+nyqbD4ZccZ7iu2HJkAEQIiLJyhyDGK1hKigKW9vb1132lMkufPn9cKVSys
f5EIY8unwuKXHWe4ndhyZAJECIiwcIZqTZonEQ0MDNTNUzNW43qIZ8+eWRHGClWVYKhFNblYWPzY
cfrbiS1HJkCEgAhLZ2q8D1cDPH78eO17jVCnkd7EgQMHzNWrV6dNhDlh8cuOs2gclKLlyASIEBBh
cqGxsbG6wqJApYruPDk5aTsx/BHrWi3CKmHxw+MsS1u4HJmAcwGIsHCGIjqrp1UUjWOsmuCePXtM
f39/JbGlwuOH36XC4seO099OKj2IEAARFjY3Nfyle6TFScThxioO3xRJiS0VHr/ou1hY/Nhx+ttJ
pQcRAiDCykhG6jQBRAjQkSJUE1W1NHpfESFAx4pQ9/l6enrqOkkAEQJ0XNMYECEAIgRECIAIAREC
IEJAhACIEBAhACIERAiACAERAiBCQIQAiBAQIQAiBEQIgAgBEQIgQkCEAIgQECHArC4DFAQkCIAI
KRBIEAAR1hcMps6ZAKBAhNSMAAARIkIAQISIEAAQISIEAESICAEAESJCAECEiBAAECEiBABEiAgB
ABEiQgBAhIgQABAhIgQARIgIAQARIkIAQISIEAAQISIEAESICAEAESJCAECEiBAAECEiBABEiAgB
ABEiQgBAhIgQABAhIgQARIgIAQARIkIAQISIEAAQISIEAESICAEAESJCAECEiBAAECEiBABE2I4C
DCcAQISIEAAQYSfLEAAQISIEAESICAEAESJCAECEnStDAECEiBAAEGHYTGRq/wkAAhFSMKgJA3S0
CCkQyBCgw8sBBYFMQB4ARMhZIBNwEgARAiIEQISACAEQISBCAEQIiBAAEU4n4+PjnGlECDB7Rfjl
yxezevXqpnYyf/78X1pYh4eHza5du2qfP3/+bA4dOmQWLlxoj62vr898/PgREQIgwh/59u2b2bt3
b9MFpRUFrZltbNiwwbx8+bL2+ciRI+by5cvm+/fvdjpx4oSVISIEQIQ/sH37dvPmzZusgnL//n0z
b948M3fuXLN+/XozOjpaK2Th+61F2/O/k5wOHz5sFi1aZLq6uszNmzft/ImJCdPd3V0o7OXLl5up
qakf5j1+/Nj09PTUfbdkyRK7D3/9VtRaESFAG4pwZGQku6BIgg8ePKg1RVetWlVa0FIivHjxojl7
9qyV1fv3783WrVtr83fs2FGTrOP69evm4MGDhcel2t/Q0FD02L9+/WqWLVuGCAEQYXMFRSK5detW
1vopEW7cuNHKyfHs2bPa/Hv37pne3t66dbX88+fPC/e9adMm8+LFi+ix//XXX+bUqVOIEAARNldQ
VAvUcrofNzAw0JQIVbv0Uc3Qn79ixYraPT9JUiIsY8GCBXXN4JAPHz6Yffv22eYxIgRAhE0XlKdP
n9ZqbMePH2+ZCMP5Z86csb2+4sCBA+bq1aulx6R7lmVIfr///rttfnd4JqAkACJsdUEZGxurWycl
wtevX9d9t3nz5rqmsZq2/nyJSzW9yclJs3jxYvuIT9UaoWqCkqn2TSZAhIAIW1JQ1q5da3uOhTpN
/FqdZPT27dua3PyOFfVK7969u24fN27csLU+11miDpLwGFQT3LNnj+nv748el+4Rqvnso57kbdu2
WZECIgRomQjVLF63bp1tikp0Tori3Llz9vEU94iKE6WW1cPaWjbcx/nz583SpUttje/KlSs/zH/y
5In9LvXWinqNtb6PHrUhdD0iBKgkwpnIu3fvbKdJCglTz0MCIgRoKxGqyXzy5MkfeqfLUE827zsj
QoC2EqHuOeptkVgniY+a4rqfCIgQoK2axoAIARAhIEIARAiIEAARAiIEQISACAEQISBCgE4UYe7x
6rW9hw8f/hQB/OoI3jMhgjgAIpyBIlSYrlh4rplUo0KEADNUhPpe7w8r4KovlNOnT9v3fzXw0dGj
R+vWUVAFBUPQA89r1qyxr7f5aGwQraf5eu1NgRhi+ysL2e8oGx7AoYeuFWAhRwD6X5Gu9dqee1/a
BYZIpS0WaSf8LpWm1DnOWR8RArRQhIrsooKn93qFghdIFvpOsfxUCBVQwaEozy5KteISKiKN48KF
C+bSpUu1AZO0LYkltr9YyH4RGx5AXLt2zQZdyBWhmtNOzmEEnVjaqogwlabUOU6tjwgBWixCv8Ym
9M5uGNvPl4/kUBYNWpFp/BiD+l/RZWL7i4XsF7HhAYTiGCoMV64Iw/3782NpqyLCVJpS5zi1PiIE
aLEIQ1RDCkNX+RGgiyJLO4oiRfvLl+0vbBb6y8WGB3DLq3mZK8LY/FjamtlOmKaq5zhcHxECTLMI
Y2HvU7JIhd/PEWHRcmXDA0y3wFq5HX9+I+cYEQL8RBGqQ+LTp0+lG1OQ1bLmo9YNm8b+WMJF+0uF
7PcJhwcQusfWqhphLG2x7VQdhiB1jqucE0QIMA0iVIeHu1GvSZ/9oKfqUFBzVegZvrCzZHBwsLbu
5cuXrVxi+0uF7I8NDyA0xGeVe4Sx+bG0lXXgNDIMQeoc5wxjgAgBplGEQgFR9eiGanMq5K6HVyg+
YF9fn5WBOkfCsULc4zOa1GM8MTGR3F8sZH9seACh0e2q9BrH5sfS5i/XimEIYuc4Z31ECNAiEbYD
erREsgRECNCRItS9M/UmAyIE6FgRKjR/6l1jQIQAbd80BkQIgAgBEQIgQkCEAIgQECEAIgRECNCR
IhwfH29oXiuWR4QAbSTC2Vw4/HeYw7SE85rZFiIEoEY4Kwt21fR2giQQISDCjBphKox9EXqvWO/L
Knjq0NBQpfd6X716Zd+xVVh87Uuh8e/cuZN1PGEsP3/bRfNi+yrb1tTUlFm+fLl9/9hHUWEUPcYR
C7mPCAFmoQhjYexDFE7eRUhRwABFVa4iwu7ubhtlxUVgUYh/CTX3eMLtx/ads6+ibR06dMhGhgnT
LfmJVMh9RAgwC0UYC2Mfond8/dqSBjqqIsIi/IClqeOpIsKcfRVtS6PkqVboYhTq78qVK2vHlQq5
jwgBZqEIqxSeVDj5nO0paoxiAO7fv9+GvaqyflURVtmX/3nbtm221idUq1Qt1T8HsZD7iBCgw0RY
dXu6p6jApxqFbmRkxDavp0uEVfflf9YQAbqnKHRvUOsX1SpnQSagJAAibLUIt2zZYj5+/Fj7HIaT
T4WzVyeLH64+nN9KEVbdV/hZHTa6N6hmsU8q5D4iBGhzEd6+fdv2GpeFk0+Fs5dcXM+tG5KzyvGo
B1j36tzYHrF5qX3FtiXUAaKB1sOOkFTIfUQI0OYiFOo1Ve/rb7/9ZkVTJZz9o0ePbMeCllGzVWMX
VzkeSUkPQruHoWPzUvuKbUt8+PDBzpPwQ1Ih9xEhwAwXIYWtozIBJwEQIYUNEQIgwp9A1Xd8AREC
tJ0IARECIEJAhACIEBAhACIERAiACAERAiBC0xmh7xEhACKM8jND31PAOU8AM1KEqSAGgAgBZowI
9f6vex9YkVRGR0fNxMSEjegcogjMClKqEPaNhNEfHByMDgMQC3lfdJxFBTy2HJkAEQIiLJzhC2l4
eLgWXVmRZEKJSHwHDx6sFaqqYfR37dpVunwq5H3ZcYb7ii1HJkCEgAgLZyhyjCKxhCgYaW9vb913
GpPk+fPntUJVNYx+bPlUyPuy4wy3E1uOTIAIAREWzlCtSfMkooGBgbp5asZqzA7x7NkzK8JYoaoS
6LSoJhcLeR87Tn87seXIBIgQEGHpTI3l4WqAx48fr32vEeo0ips4cOCAuXr16rSJMCfkfdlxFo2D
UrQcmQARAiJMLjQ2NlZXWBSEVJGbJycnbSeGP2Jdq0VYJeR9eJxlaQuXIxNwLgARFs5QtGb1tIqi
cYxVE9yzZ4/p7++vJLZU6Pvwu1TI+9hx+ttJpQcRAiDCwuamhrZ0j7Q4iTjcWMXhmyLNhNEv20Ys
5H3sOP3tpNKDCAEQYWUkI3WaACIE6EgRqomqWhq9r4gQoGNFqPt8PT09dZ0kgAgBOq5pDIgQABEC
IgRAhIAIARAhIEIARAiIEAARAiIEQISACAEQISBCAEQIiBAAEQIiBECEgAgBECEgQgBECIgQYFaX
AQoCEgRAhBQIJAiACOsLBlPnTADw//wfS69uCROMVAEAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2016-07-26 23:32:01 +0100" MODIFIED_BY="Luisa M Fernandez Mauleffinch" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASEAAAFzCAIAAAD+OSiwAAAPq0lEQVR42u3dvW5dxRrG8S0hIQoX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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2016-07-25 14:40:59 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2016-07-25 14:39:09 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2016-07-25 14:38:34 +0100" MODIFIED_BY="[Empty name]">MEDLINE Ovid search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-25 14:39:09 +0100" MODIFIED_BY="[Empty name]">
<P>1. exp Orthodontics/<BR/>2. (orthodontic$ or (orthopaedic adj appliance$)).ti,ab.<BR/>3. (mandibular adj3 advanc$).ti,ab.<BR/>4. (Kinetor or Bimler or Frankel or Harvold or Andresen or bionator$ or<BR/>Herbst).ti,ab.<BR/>5. (function$ adj6 regulator$).ti,ab.<BR/>6. (Bass adj6 appliance$).ti,ab.<BR/>7. "bite block$".ti,ab.<BR/>8. ((Herren or Woodside) and activat$).ti,ab.<BR/>9. (activator adj3 appliance$).ti,ab.<BR/>10. ((dental or oral or intraoral or tongue or mandibular) adj3 appliance).ti,ab.<BR/>11. (mandibular adj3 prosthes$).ti,ab.<BR/>12. or/1-11<BR/>13. exp Sleep apnea syndromes/<BR/>14. Snoring/<BR/>15. (sleep adj3 (apnea or apnoea or hypopnea or hypopnoea)).ti,ab.<BR/>16. ("upper airway resistance" or "sleep disordered breathing" or snor$).ti,ab.<BR/>17. or/13-16<BR/>18. 12 and 17</P>
<P>The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in MEDLINE: sensitivity maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of the<I> Cochrane Handbook for Systematic Reviews of Interventions </I>Version 5.1.0 (updated March 2011) (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>1. randomized controlled trial.pt.<BR/>2. controlled clinical trial.pt.<BR/>3. randomized.ab.<BR/>4. placebo.ab.<BR/>5. drug therapy.fs.<BR/>6. randomly.ab.<BR/>7. trial.ab.<BR/>8. groups.ab.<BR/>9. or/1-8<BR/>10. exp animals/ not humans.sh.<BR/>11. 9 not 10</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2016-07-24 22:54:38 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2016-07-01 15:28:32 +0100" MODIFIED_BY="[Empty name]">Cochrane Oral Health's Trials Register search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-01 15:28:49 +0100" MODIFIED_BY="[Empty name]">
<P>1 (orthodontic* or (orthopaedic next appliance*)):ti,ab<BR/>2 (mandibular and advanc*):ti,ab<BR/>3 (Kinetor or Bimler or Frankel or Harvold or Andresen or bionator* or Herbst):ti,ab<BR/>4 (function* and regulator*):ti,ab<BR/>5 (Bass and appliance*):ti,ab<BR/>6 "bite block*":ti,ab<BR/>7 ((Herren or Woodside) and activat*):ti,ab<BR/>8 (activator and appliance*):ti,ab<BR/>9 ((dental or oral or intraoral or tongue or mandibular) and appliance*):ti,ab<BR/>10 (mandibular and prosthes*):ti,ab<BR/>11 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10<BR/>12 (sleep and (apnea or apnoea or hypopnea or hypopnoea)):ti,ab<BR/>13 ("upper airway resistance" or "sleep disordered breathing" or snor*):ti,ab<BR/>14 #12 or #13<BR/>15 #11 and #14</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2016-07-25 14:39:45 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2016-07-25 14:39:45 +0100" MODIFIED_BY="[Empty name]">Cochrane Central Register of Controlled Trials (CENTRAL) search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-01 15:29:23 +0100" MODIFIED_BY="[Empty name]">
<P>#1 [mh orthodontics]<BR/>#2 (orthodontic* or (orthopaedic next appliance*)):ti,ab<BR/>#3 (mandibular near/3 advanc*):ti,ab<BR/>#4 (Kinetor or Bimler or Frankel or Harvold or Andresen or bionator* or Herbst):ti,ab<BR/>#5 (function* near/6 regulator*):ti,ab<BR/>#6 (Bass near/6 appliance*):ti,ab<BR/>#7 "bite block*":ti,ab<BR/>#8 ((Herren or Woodside) and activat*):ti,ab<BR/>#9 (activator near/3 appliance*):ti,ab<BR/>#10 ((dental or oral or intraoral or tongue or mandibular) near/3 appliance*):ti,ab<BR/>#11 (mandibular near/3 prosthes*):ti,ab<BR/>#12 {or #1-#11}<BR/>#13 [mh "Sleep apnea syndromes"]<BR/>#14 [mh ^Snoring]<BR/>#15 (sleep near/3 (apnea or apnoea or hypopnea or hypopnoea)):ti,ab<BR/>#16 ("upper airway resistance" or "sleep disordered breathing" or snor*):ti,ab<BR/>#17 {or #13-#16}<BR/>#18 #12 and #17</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2016-07-25 14:40:59 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2016-07-25 14:33:59 +0100" MODIFIED_BY="[Empty name]">Embase Ovid search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-25 14:40:59 +0100" MODIFIED_BY="[Empty name]">
<P>1. Orthodontics/<BR/>2. (orthodontic$ or (orthopaedic adj appliance$)).ti,ab.<BR/>3. (mandibular adj3 advanc$).ti,ab.<BR/>4. (Kinetor or Bimler or Frankel or Harvold or Andresen or bionator$ or Herbst).ti,ab.<BR/>5. (function$ adj6 regulator$).ti,ab.<BR/>6. (Bass adj6 appliance$).ti,ab.<BR/>7. "bite block$".ti,ab.<BR/>8. ((Herren or Woodside) and activat$).ti,ab.<BR/>9. (activator adj3 appliance$).ti,ab.<BR/>10. ((dental or oral or intraoral or tongue or mandibular) adj3 appliance).ti,ab.<BR/>11. (mandibular adj3 prosthes$).ti,ab.<BR/>12. or/1-11<BR/>13. exp Sleep disordered breathing/<BR/>14. Snoring/<BR/>15. (sleep adj3 (apnea or apnoea or hypopnea or hypopnoea)).ti,ab.<BR/>16. ("upper airway resistance" or "sleep disordered breathing" or snor$).ti,ab.<BR/>17. or/13-16<BR/>18. 12 and 17</P>
<P>The above subject search was linked to adapted version of the Cochrane Embase Project filter for identifying RCTs in Embase via Ovid (<I>see</I> <A HREF="http://www.cochranelibrary.com/help/central-creation-details.html">http://www.cochranelibrary.com/help/central-creation-details.html</A> for information):</P>
<P>1. Randomized controlled trial/<BR/>2. Controlled clinical study/<BR/>3. Random$.ti,ab.<BR/>4. randomization/<BR/>5. intermethod comparison/<BR/>6. placebo.ti,ab.<BR/>7. (compare or compared or comparison).ti.<BR/>8. ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab.<BR/>9. (open adj label).ti,ab.<BR/>10. ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab.<BR/>11. double blind procedure/<BR/>12. parallel group$1.ti,ab.<BR/>13. (crossover or cross over).ti,ab.<BR/>14. ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab.<BR/>15. (assigned or allocated).ti,ab.<BR/>16. (controlled adj7 (study or design or trial)).ti,ab.<BR/>17. (volunteer or volunteers).ti,ab.<BR/>18. trial.ti.<BR/>19. or/1-18<BR/>20. (exp animal/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans).ti.)<BR/>21. 19 not 20<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-05" MODIFIED="2016-07-25 14:38:19 +0100" MODIFIED_BY="[Empty name]" NO="5">
<TITLE MODIFIED="2016-07-25 14:38:19 +0100" MODIFIED_BY="[Empty name]">LILACS and BBO BIREME search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-01 15:31:47 +0100" MODIFIED_BY="[Empty name]">
<P>(Tw sleep AND TW apnoea) OR (TW SLEEP AND APNEA) OR (SLEEP AND APNEA AND SYNDROME$) OR (SLEEP AND APNOEA AND SYNDROME$) OR TW SNORING OR (Tw upper AND TW airway AND TW resistance AND TW syndrome$) OR (TW APNEIA AND TW SONO) OR (TW SINDROME$ AND APNEIA AND SONO) OR TW RONCO OR (Tw sindrome$ AND TW aumento AND TW resistencia AND TW via$ AND TW aerea$ AND superior$) [Words]</P>
<P>AND<BR/>
<BR/>(TW FUNCTIONAL AND TW ORTHODONTIC AND TW APPLIANCE$) OR (TW ORTHODONTIC AND TW APPLIANCE$ AND TW REMOVABLE) OR (TW ACTIVATOR AND TW APPLIANCE$) OR (Tw mandibular AND TW advancement AND TW appliance$) OR (Tw oral AND TW appliance$) OR KINETOR OR (TW AND TW BIMLER AND TW APPLIANCE$) OR (Tw Frankel AND TW appliance$) OR (TW FRANKEL AND TW FUNCTION AND TW REGULATOR$) OR (Tw functional AND TW regulator$) OR (TW HARVOLD AND TW ACTIVATOR$) OR (TW ANDRESEN AND TW APPLIANCE$) OR (Tw bass AND TW appliance$) OR TW BIONATOR OR (Tw bite AND TW block) OR (TW HERBST AND TW APPLIANCE$) OR (Tw herren AND TW activator$) OR (Tw woodside AND TW activator$) OR (Tw dental AND TW device$) OR (Tw intraoral AND TW device$) OR (Tw oral AND TW device$) OR (Tw anterior AND TW mandibular AND TW positioning AND TW device$) OR (Tw tongue AND TW device$) OR (Tw mandibular TW device$) OR (Tw mandibular AND TW advancement AND TW device$) OR (Tw dental AND TW appliance$) OR (Tw tongue AND TW appliance$) OR (Tw mandibular AND TW appliance$) OR (Tw intraoral AND TW appliance$) OR (Tw mandibular AND TW advancement AND TW splint$) OR (Tw MANDIBULAR AND TW PROSTH$) OR ((TW CORRECTIVE OR TW PREVENTIVE OR TW INTERCEPTATIVE) AND TW ORTODONTIC$) OR (Tw aparelho$ AND TW ortodontico$ AND TW funciona$) OR (Tw aparelho$ AND TW ortodontico$ AND TW removive$) OR (Tw aparelho$ AND TW ativador$) OR (Tw aparelho$ AND TW avanco$ AND TW mandibular$) OR (Tw aparelho$ AND TW Ora$) OR (Tw Aparelho$ AND TW Bimler) OR (Tw Aparelho AND TW Frankel) OR (Tw Regulador$ AND TW Func$ AND TW Frankel) OR (Tw regulador$ AND TW funciona$) OR (Tw ativador$ AND TW Harvold) OR (Tw Aparelho$ AND TW Andresen) OR (Tw Aparelho$ AND TW bass) OR (Tw bionator) OR (Tw bloco AND TW mordida) OR (Tw Aparelho$ AND TW Herbst) OR (Tw Ativador$ AND TW herren) OR (Tw Ativador$ AND TW woodside) OR (Tw aparelho$ AND TW intra AND TW ora$) OR (Tw aparelho$ AND TW posicionador$ AND TW mandibular$) OR (Tw aparelho$ AND TW mandibular$) OR (Tw aparelho$ AND TW denta$) OR (Tw aparelho$ AND TW lingua$) OR (Tw aparelho$ AND TW mandibular$) OR (TW ORTODONTIA AND (TW PREVENTIVA OR TW CORRETIVA OR TW INTERCEPTATIVA)) [Words]</P>
<P>The above subject search was linked to the Brazilian Cochrane Center filter for LILACs via BIREME:</P>
<P>((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation OR Mh double blind method OR Mh single blind method) AND NOT (Ct animal AND NOT (Ct human AND Ct animal))) OR ((Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$ OR Mh research design) AND NOT (Ct animal AND NOT (Ct human and Ct animal))) OR ((Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND NOT (Ct animal AND NOT (Ct human and Ct animal))) [Words]</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-06" MODIFIED="2016-07-25 14:37:25 +0100" MODIFIED_BY="[Empty name]" NO="6">
<TITLE MODIFIED="2016-07-25 14:37:25 +0100" MODIFIED_BY="[Empty name]">SciELO Web of Science search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-01 15:32:57 +0100" MODIFIED_BY="[Empty name]">
<P>#6 #1 and #5<BR/>#5 #2 or #3 or #4<BR/>#4 TS=((aparelho* AND ortodontico* AND funciona*) OR (aparelho* AND ortodontico* AND removive*) OR (aparelho* AND ativador*) OR (aparelho* AND avanco* AND mandibular*) OR (aparelho* AND ora*) OR (regulador* AND funciona*) OR (Aparelho* AND bass) OR (bloco AND mordida) OR (Ativador* AND herren) OR (Ativador* AND woodside) OR (aparelho* AND intra AND ora*) OR (aparelho* AND posicionador* AND mandibular*) OR (aparelho* AND mandibular*) OR (aparelho* AND denta*) OR (aparelho* AND lingua*) OR (aparelho* AND mandibular*) OR (CORRETIVA AND ORTODONTIA) OR (PREVENTIVA AND ORTODONTIA) OR (INTERCEPTATIVA AND ORTODONTIA) OR (apararato* AND ortodonc* AND funciona*) OR (aparato* AND ortodonc* AND removi*) OR (aparato* AND activador*) OR (aparato* AND avanco* AND mandibula*) OR (aparato* AND ora*) OR (regulador* AND funciona*) OR (Aparato* AND bass) OR (Activador* AND herren) OR (Activador* AND woodside) OR (aparato* AND intra AND ora*) OR (aparato* AND posicionador* AND mandibular*) OR (aparato* AND mandibular*) OR (aparato* AND denta*) OR (aparato* AND lengua*) OR (aparato* AND mandibular*) OR (CORRECTIVA AND ORTODONC*) OR (PREVENTIVA AND ORTODONC*) OR (INTERCEPTIVA AND ORTODONC*))<BR/>#3 TS=(Harvold OR Andresen OR (bass AND appliance*) OR bionator* OR (bite AND block) OR Herbst OR (herren AND activator*) OR (woodside AND activator*) OR (dental AND device*) OR (intraoral AND device*) OR (oral AND device*) OR (tongue AND device*) OR (mandibular AND device*) OR (dental AND appliance*) OR (tongue AND appliance*) OR (mandibular AND appliance*) OR (intraoral AND appliance*) OR (mandibular AND advancement AND splint*) OR (MANDIBULAR AND PROSTH*) OR (CORRECTIVE AND ORTHODONTIC*) OR (PREVENTIVE AND ORTHODONTIC*) OR (INTERCEPTIVE AND ORTHODONTIC*))<BR/>#2 TS=((FUNCTIONAL AND ORTHODONTIC AND APPLIANCE*) OR (ORTHODONTIC AND APPLIANCE* AND REMOVABLE*) OR (ACTIVATOR AND APPLIANCE*) OR (mandibular AND advancement AND appliance*) OR (oral AND appliance*) OR Kinetor* OR Bimler OR Frankel OR (functional AND regulator*))<BR/>#1 TS=((sleep AND apnoea) OR (SLEEP AND APNEA) OR SNORING OR (upper AND airway AND resistance AND syndrome$) OR (APNEIA AND SONO) OR RONCO OR (sindrome* AND aumento AND resistencia AND via* AND aerea* AND superior*) OR (APNEA AND SUENO) OR RONQUIDO OR (sindrome AND aumento AND resistencia AND via AND aerea AND superior))</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-07" MODIFIED="2016-07-01 15:32:42 +0100" MODIFIED_BY="[Empty name]" NO="7">
<TITLE MODIFIED="2016-05-26 19:12:17 +0100" MODIFIED_BY="[Empty name]">ClinicalTrials.gov search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-01 15:32:42 +0100" MODIFIED_BY="[Empty name]">
<P>orthodontic and sleep apnea<BR/>orthopedic and sleep apnea</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-08" MODIFIED="2016-07-25 14:35:13 +0100" MODIFIED_BY="[Empty name]" NO="8">
<TITLE MODIFIED="2016-07-25 14:35:13 +0100" MODIFIED_BY="[Empty name]">World Health Organization International Clinical Trials Registry Platform search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2016-07-01 15:32:24 +0100" MODIFIED_BY="[Empty name]">
<P>orthodontic and sleep apnea or orthodontic and sleep apnoea<BR/>orthopedic and sleep apnea or orthopedic and sleep apnoea or orthopaedic and sleep apnea or orthopaedic and sleep apnoea</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study (2 records) included in quantitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;1 study (2 records) included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;7 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;686 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;686 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;1173 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;679 records discarded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;3 studies (5 records) excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>